SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
ENVIRONMENTAL, SOCIAL ANDGOVERNANCE (ESG) REPORT 2024
CONTENTS
Corporate governanceCorporate governance structureSafeguarding shareholders' rights and interests
ESG governanceESG governance structureCommunication with stakeholdersAssessment of important issuesCompliance in OperationRisk management and controlProbity and self-disciplineInformation security
Product Quality and SafetyQuality management systemProduct quality and safety management
Focusing on R&D and Innovation
Ever-improving R&D and innovation system
R&D and innovation capabilityR&D and innovation resultsIntellectual property protectionSupply Chain Management
Supplier managementSupplier communicationSustainable supply chain management
Responsible MarketingResponsible marketing management
Responsible brand buildingResponsible marketing trainingCustomer Service QualityCustomer service management and capabilities
Customer satisfactionImproving customer service capabilities
Environmental andoccupational health andsafety managementAddressing Climate Change
Green OperationEmissions and waste managementResource utilization management
Attraction and Retention of
TalentsDiversity and equal employmentEmployee rights and benefitsEmployee care and communicationEmployee Training and
DevelopmentTraining systemEmployee ability improvementEmployee promotion and developmentOccupational Health and
Safety
Occupational healthSafe production
Industry exchange and
cooperationIndustry-University-Researchcollaboration and multi-center research
Academic extensionDriving industry standardization International exchanges and cooperation
Community Commonweal Support for research and educationSupporting community commonweal
ABOUT THIS REPORTMESSAGE FROM THE CHAIRMAN
ABOUT SNIBESNIBE IN 2024
MilestonesKey PerformanceHonors and Recognitions
Key Performance Indicator Table
Appendix
0102030405REGULATING
CORPORATEGOVERNANCE
STRICTLY CONTROLLING
THE QUALITY OFPRODUCTS AND SERVICES
PROMOTING GREEN
OPERATION
TALENT
EMPOWERMENT
FULFILLING SOCIALRESPONSIBILITY
As a national enterprise with the mission of "creating value for humanhealth", we ?rmly believe that the value of an enterprise lies not merely ingenerating economic returns, but more importantly in advancing humanhealth and welfare with scientific and technological innovation, and inaddressing the pressing challenges of our era through steadfast corporateresponsibility. Snibe actively ful?lls its social responsibility, practices theconcept of sustainable development, and contributes to the high-qualityeconomic and social development by regulating corporate governance,focusing on R&D and innovation, strictly controlling the quality of productsand services, dedicating to talent introduction and cultivation, promotinggreen operation, and effectively preventing environmental, social, andgovernance risks in production and operation.We continuously regulate corporate governance. We have consolidatedthe institutional foundation of standardized governance, carriedout audits and inspections with solid efforts, and promoted anti-commercial bribery compliance work. In order to protect the rights andinterests of shareholders, especially small and medium shareholders,we attach importance to the quality of information disclosure andactively hold and participate in investor exchange activities in diverseways to improve investors' understanding of the Company. In order toimplement the sustainable development strategy, we have establishedthe ESG governance framework and optimized the internal sustainablemanagement.We are committed to independent innovation. We focus on the ?eld of invitro diagnosis. Through continuous technological innovation and productdevelopment, we continue to break through the industry's limits in single-machine speed measurement of chemiluminescence immunoassayinstruments, and have developed a number of user-recognized instrumentproducts and IT solutions, helping to improve the accuracy and e?ciencyof detection, and achieving revolutionary technological breakthroughsin the field of small molecule detection. Maintaining a sustainedcommitment to R&D in rare disease diagnostics and testing solutions forgeriatric, pediatric, and maternal health, we persistently create value forhuman health.We strictly control the quality of products and services. On the longjourney of serving people's health, Snibe is committed to leveragingscience and technology and developing products for good and ful?lling itscommitments in a pragmatic way. With the spirit of "Quality is our life", westrive to optimize and upgrade the product quality management system,strengthen the quality of the supply chain and sustainable management,further improve the quality control of the entire product chain, providedoctors with more accurate and reliable test results, and continuouslyreduce the cost of patient diagnosis and treatment.We continue to promote green operation. We attach great importanceto environmental management and occupational health and safetymanagement, embedding the concept of green operation and safetyinto all aspects of daily operation. Through continuous technologicalupgrades, equipment and method optimization, we systematicallyenhance the e?ciency of energy and resources. In 2024, we were awardedthe ISO 14064-1:2018 Certi?cate of Greenhouse Gas Veri?cation Statementfor the ?rst time.We grow together with our employees. We regard talents as the coreresources of Snibe, adhere to diverse and equal employment, andattract and reserve talents in all respects through equal employment
This is the fourth Environmental, Social and Governance (ESG) report issued byShenzhen New Industries Biomedical Engineering Co., Ltd. According to the principlesof objectivity, standardization, transparency, and comprehensiveness, this reportdiscloses detailed information concerning the Company's practice and performancein the field of sustainable development in 2024, such as environment, society, andgovernance.This report is an annual report and covers relevant data from Jan. 1, 2024 to Dec. 31,2024. As some of the data in this report involve continuity and comparability, somecontents are appropriately extended or traced as needed.This report covers Shenzhen New Industries Biomedical Engineering Co., Ltd. and itssubsidiaries.This report is mainly prepared with reference to the "Global Reporting Initiative(GRI) Standards", "Shenzhen Stock Exchange Self-Regulation Guidelines forListed Companies No. 17 - Sustainable Development Report (Trial)", "ShenzhenStock Exchange ChiNext Self-Regulation Guidelines for Listed Companies No. 3- Sustainable Development Report Preparation", and the United Nations "Guidefor Business Action on the Sustainable Development Goals (SDGs)", in order tocontinuously improve the transparency of the disclosure of sustainable developmentreports and respond to the information needs of stakeholders.For better elaboration and understanding, "Shenzhen New Industries BiomedicalEngineering Co., Ltd." is also referred to as "Snibe", "We", or "the Company" in thisreport.The monetary amounts in this report are measured in RMB unless otherwise specified.This report was approved for release at the 3rd Meeting of the 5th Board of Directorsof the Company on Apr. 25, 2025. The Company and all members of the Board ofDirectors warrant that the contents disclosed in this report are true, accurate, andcomplete, and that there are no false records, misleading statements, or majoromissions.This report includes paper and electronic versions. You can read and download theelectronic version of this report on Juchao Information Network (www.cninfo.com.cn), the designated information disclosure website of the Shenzhen Stock Exchange,or the official website of Snibe (www.snibe.com), and obtain more companyinformation. If you have any questions or suggestions about this report, please sendan email to Snibeinfo@snibe.cn or call +86-755-86540062.This report is prepared in Chinese. The English version is the translation of theChinese version. If there is any ambiguity in the understanding of the English version,the Chinese version shall prevail.
Overview
Scope of Reporting
Standards forReporting
Explanation
Confirmation andApproval
Access to theReport andFeedback
ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024
ABOUT THIS REPORTMESSAGE FROM THE CHAIRMAN
01/Environmental, Social and Governance (ESG) Report 2024/02Environmental, Social and Governance (ESG) Report 2024
Chairman: Rao WeiApr.25, 2025to continuously bring fresh blood to the development ofthe Company. We have customized diversified trainingprograms as well as promotion and development channelsfor employees, established a perfect salary and benefitsystem and incentive mechanism, provided a comfortableworking environment, and taken various welfare and caremeasures to create a highly sticky environment for talents,with a commitment to empowering employees to achieve thesuccess of the Company and growth of both the employeesand the Company.We ful?ll social responsibility. While pursuing the company'sdevelopment, we have always been committed to socialwelfare and corporate social responsibility. Relying on ourcore competencies and technological expertise, we activelyparticipate in industry exchanges and cooperation, as wellas the popularization of medical examination knowledgeto promote the development of the industry. Throughstrategic partnerships with leading healthcare institutions,we drive translational research to enable early diagnosisand treatment of chronic diseases. We support scientificresearch and education by cultivating diagnostic talents, andaccelerating education and medical research.Sustainable development is an enduring journey. Guided byunwavering reverence for human life and health, we harnessinnovation to address evolving healthcare imperativesand uphold our corporate mission through responsiblestewardship. Within the grand vision of global healthcare,we are committed to scripting an illustrious chapter thatexemplifies Chinese enterprises' contributions to medicalprogress. We are sincerely grateful to all colleagues for theirtrust and support. Together, let us forge a healthier, moreequitable, and sustainable future for all!
"Multi-center Research on Improvementof Hepatocellular Carcinoma ScreeningEcacy Through Multiple Indices"project was successfully concludedThe project "Multi-center Research onImprovement of Hepatocellular CarcinomaScreening E?cacy Through Multiple Indices",led by Peking University, supported by theCompany, and conducted across ten nationallyrenowned Grade A tertiary hospitals, has beensuccessfully concluded in Shenzhen. Basedon the big data from Chinese chronic hepatitisB population, this multi-center research hasestablished the GADA model, an auxiliarydiagnostic system for liver cancer, and thesupporting GADA software for early screeningof liver cancer.
Since its founding in 1995, Snibe has focused on the ?eld of IVD and developed itself into a national high-tech enterprise specializingin the R&D, production, sales, and services of IVD products. Since its inception, the Company has dedicated itself to the mission of"customer-centric, market-oriented, creating value for human health through continuous innovation" to provide customers withbetter IVD products and services.The Company has established four technical platforms covering the R&D of magnetic microspheres, key reagent materials, automaticdiagnostic instruments, and diagnostic reagents. As of the end of the reporting period, regarding the leading immunodiagnosticproduct line, the Company has sold 10 fully-auto chemiluminescence immunoassay analyzers and 224 supporting reagents tothe global market, including 198 chemiluminescence reagents that have obtained EU marketing authorization and 7 products thathave obtained FDA 510(k) clearance. By now, the Company has obtained domestic medical device registration certi?cates for 193chemiluminescence reagents and 67 biochemical reagents.After 29 years of profound development, technology iteration, and customer accumulation, the Company's products have brokenthe monopoly and technology blockade of overseas giants on China's IVD market, and Snibe has become a leader in China's IVD?eld and is evolving into a pioneer in the global IVD ?eld. By the end of 2024, the Company's products were sold to 160 countriesand regions overseas. To promote the expansion to overseas markets, the Company has gradually subdivided overseas markets,implemented regional management mode, and developed localized operation strategies on overseas markets to stimulate overseasbusiness. By now, the Company has established 14 overseas subsidiaries.
The kick-o meeting of "Multi-centerResearch on Aldosterone and ReninReference Interval Establishment in DierentRegions of China" was successfully heldThe Company, in collaboration with PekingUniversity People's Hospital and multiple clinicalinstitutions across China, has launched "Multi-center Research on Aldosterone and ReninReference Interval Establishment in Di?erentRegions of China".
The intelligent laboratory solutionSATLARS T8 was releasedSATLARS T8, a new industrial intelligentlaboratory solution, was released atthe CACLP exhibition in Chongqing.The rollout of SATLARS T8 not onlyembodies the culmination of thecompany's longstanding technologicalprowess but also represents a strategicinitiative to address evolving marketdemands and intensifying industrycompetition.
The overall intelligent laboratory solutioniXLAB was releasedThe 18th National Congress of Laboratory Medicine(NCLM 2024) was held in Hangzhou. With anunwavering commitment to technological innovationand medical advancement through intelligentscienti?c research, the Company ?nally released theoverall intelligent laboratory solution iXLAB at thecongress.
New Industries BiomedicalOperational Buildingachieves topping-outmilestoneAfter more than 600 daysof construction, the mainstructure of the New IndustriesBiomedical OperationalBuilding has successfullyachieved topping-out. Thislandmark accomplishment notonly signi?es a critical phasecompletion in the project'sengineering execution but alsostands as a critical milestonein the company's growthtrajectory.
As of the end of the reporting period, the actual controller of Snibe is Mr. Weng Xianding, whose direct shareholding ratio is
3.18% and shareholding ratio through Tibet New Industry Investment Management Co., Ltd. is 26.88%, totaling 30.06%. The
second largest shareholder is Rao Wei, the general manager of the Company, with a shareholding ratio of 13.77%. The thirdlargest shareholder is Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership), with a shareholding ratio of
11.64%.
Company Introduction
Milestones
Company's Ownership Structure
Corporate Culture
Customer-centric,market-oriented,creating value forhuman health throughcontinuous innovation.
To be a leader in China'sIVD fieldTo be a pioneer in theglobal IVD fieldAssume responsibilitybravelyEnjoy challengepersistentlyPursue excellencepassionately
Quality is our lifeMissionVisionCore valuesSpirit
ABOUT SNIBESNIBE IN 2024
0103020504
ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024
03/Environmental, Social and Governance (ESG) Report 2024/04Environmental, Social and Governance (ESG) Report 2024
Snibe won the 2024 China Medical Device"National Brand Gold Award" and "TopProduct Line" honor
In the "2024 China Medical Device Industry DataSurvey" project organized by China Medical Devicesmagazine, Snibe won the 2024 China MedicalDevice "National Brand Gold Award" and "TopProduct Line" honors, re?ecting the customer's fullrecognition of our products and services.
Snibe's tumor markers and thyroid testingpanel were all included in Group A ofcentralized procurement in 28 domesticprovinces
In the inter-provincial centralized volume-basedprocurement of IVD reagents among 28 provinces(districts and corps) led by Anhui MedicalInsurance Bureau in 2024, Snibe's tumor markersand thyroid testing panel were all included inGroup A. The intention procurement volume oftumor markers accounted for 10.4% of the totalintention procurement volume, ranking top three,and the intention procurement volume of thyroidtesting panel accounted for 9.3% of the totalintention procurement volume, ranking top ?ve.
Saudi Ministry of Healthand NUPCO visited Snibeto jointly promote thedevelopment of medicalhealth
His Excellency Fahad bin Al-jalajel, Minister of Health of theKingdom of Saudi Arabia, and Mr.Fahad AlShebel, CEO of the SaudiNational Uni?ed ProcurementCompany (NUPCO), led adelegation to visit Snibe. NUPCOand the Company signed aMemorandum of Understanding(MoU) to jointly explore andadvance the development ofhealthcare in Saudi Arabia.
Snibe was listed inForbes Asia's BestUnder A Billion 2024List and ForbesChina ESG 50Forbes Asia's BestUnder A Billion Listspotlights 200 top-performing publiclylisted companies withannual sales under$1 billion in the Asia-Paci?c region, andSnibe's inclusion in thislist represented theexternal recognition ofour performance.While pursuingdevelopment, Snibeattached greatimportance to corporatesocial responsibility,and was included in2024 "Forbes China ESG50" list.
0608071009
Snibe won the awardof "Shenzhen Top 10Model Platforms forLifelong VocationalSkills Training"In 2024, we won the awardof "Shenzhen Top 10 ModelPlatforms for LifelongVocational Skills Training"from Human Resources andSocial Security Bureau ofShenzhen Municipality.
Economic performance
Corporate governance
Quality of products and services
4,535.40
453.59
100%
Business revenue
Investor exchange
R&D investment amount
Overall satisfactionwith customercomplaint handling
MillionRMB
activitiesOver
MillionRMB
Net profit attributable to shareholdersof listed companies
Information disclosureassessment result
Cumulativenumber ofpatents filed
Earnings per share
Proportion of employeesreceiving anti-commercialbribery training
Number of globally availablechemiluminescenceimmunoreagents
Number of events resulting infines or penalties for breachof regulationsTotal number of confirmedcomplaints received relatedto infringement of customerprivacy
Proportion of employeessigning anti-commercialbribery commitments
Quality managementsystem certificates
Number of recalledproducts
1,828.46
A
2.3271
100%
100%
MillionRMB
RMB/share
ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024
05/Environmental, Social and Governance (ESG) Report 2024/06Environmental, Social and Governance (ESG) Report 2024
Key Performance
Environmental and occupational health and safety
Attraction and retention of talents
0.00750.03390.538620,870.1
2,841
72.51%
100%
Energy consumptionintensity
Carbon emissionintensity
Water intake intensityVolume of reject water
recovered
Number of employees
Proportion of employeeswith bachelor degree orabove
Coverage of occupationalhealth examination
tons of standardcoals/10,000 RMB
tons of CO
equivalent/10,000 RMB
m
/10,000 RMB
hours
Million RMB
m
Proportion of femaleemployees
Proportion of females inmanagement
Proportion of females insenior management
Total training duration
Investment in environmentaland occupational health andsafety
Proportion of employeescovered by year-endperformance appraisal
Number of employee deathsdue to work-related injuries
Social insurancecoverage
36.43%30.95%66.67%
86,482
4.095
100%
100%
National High-tech EnterpriseNational Enterprise Technology CenterNational Enterprise Technology Center2024 High-end Medical Device Promotionand Application Project
Science, Technology, and Innovation Commission of ShenzhenMunicipality, Finance Bureau of Shenzhen Municipality, and ShenzhenTax Service, State Taxation AdministrationNational Development and Reform CommissionMinistry of Industry and Information Technology of the People'sRepublic of China, and National Health Commission of the People'sRepublic of China
Product and R&D innovationIssuing authority
Master Enterprise of "Industry-Education-Assessment" SkillsEcological Chain in Guangdong ProvinceCatalog of Innovative Products for Promotion andApplication in ShenzhenListed in the "White List" of Shenzhen Entry-Exit BiomedicalSpecial Products Pilot Enterprises (Institutions) in 2024
Top 500 Enterprises in Guangdong Provincein 2024Forbes Asia's Best Under A Billion 2024 ListChina's Top 20 Most CompetitivePharmaceutical Listed Companies in 2024
Shenzhen Top 10 Model Platforms for LifelongVocational Skills Training2024 Social Enterprise ExcellenceMost Influential Employer 20252024 Employer of Excellence in Occupational Credit
Grade A in information disclosure appraisal (three consecutive years)Golden Bull Award - 2023 Golden Information Disclosure AwardBest Practices for Investor Relations Management of Listed Companies in 2023
Listed in 2024 China ESG 50Status Upgrade to BBB in MSCI ESG RatingScored AAA in CNI ESG RatingChina's Top 20 ESG-Competitive Pharmaceutical Listed Companies in 2024
Human Resources and Social Security Department ofGuangdong ProvinceIndustry and Information Technology Bureau ofShenzhen MunicipalityDevelopment and Reform Commission of ShenzhenMunicipality
Guangdong Provincial Enterprise Confederation and GuangdongProvincial Association of EntrepreneursForbesChina Pharmaceutical Enterprise Association
Human Resources and Social Security Bureau ofShenzhen MunicipalityHRoothaitou.ccGuangzhou Best Check Human Resources Co., Ltd.
Shenzhen Stock ExchangeChina Securities JournalChina Association of Public Companies
Forbes ChinaMSCIShenzhen Securities Information Co., Ltd.HEALTHCARE EXECUTIVE Magazine
Comprehensive competitiveness
Human resources
Corporate governance
ESG
Issuing authority
Issuing authority
Issuing authority
Issuing authority
ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024ABOUT THIS REPORT | MESSAGE FROM THE CHAIRMAN | ABOUT SNIBE | SNIBE IN 2024
07/Environmental, Social and Governance (ESG) Report 2024/08Environmental, Social and Governance (ESG) Report 2024
Honors and Recognitions
Product and R&D innovationIssuing authority
●Corporate governance structure
The Company, in strict accordance with the "Company Law of the People's Republic of China", the "Securities Law of thePeople's Republic of China", the "Code of Corporate Governance for Listed Companies in China", the "Rules Governing theListing of Shares on the ChiNext of Shenzhen Stock Exchange", and other relevant laws, regulations, normative documents, andrelevant requirements of China Securities Regulatory Commission, and in consideration of the actual situations of the Company,has established a corporate governance structure consisting of a board of shareholders, a board of directors, a board ofsupervisors, and a management team, and formulated and improved the "Articles of Association" and other internal controlrules and working procedures to guarantee the standardized operation of the corporate governance structure.In addition, the Board of Directors of the Company has set up four special committees: the Strategy Committee, the NominationCommittee, the Remuneration and Assessment Committee, and the Audit Committee, and formulated corresponding workingrules, which effectively ensured the standardized operation and sustainable development of the Company and formed arelatively scienti?c and standardized governance system.
Convening of three meetingsThe Company convenes and holds shareholders' meetings in a standardized manner in strict accordance with the "Rules for theShareholders' Meetings of Listed Companies", the "Articles of Association", the "Rules of Procedure for Shareholders' Meetings",and other regulations and requirements, adopts the combination of on-site voting and online voting, counts the votes of smalland medium investors separately when considering major matters a?ecting the interests of small and medium investors, anddiscloses the voting results of small and medium investors in a timely manner to ensure that all shareholders, especially smalland medium shareholders, enjoy equal status and are able to fully exercise their rights.The Board of Directors is responsible to the Board of Shareholders, and the Company convenes and holds the meeting of theBoard of Directors in strict accordance with the relevant provisions of the "Articles of Association" and the "Rules of Procedurefor the Board of Directors". Independent directors are independent of the actual controllers, controlling shareholders, and otherrelated parties of the Company, and are able to make judgments and express opinions independently to e?ectively safeguard
· Corporate governance· Investor relations· Compliance in operation· Sustainable development management· Communication with stakeholders· Information security and privacy protection· Anti-commercial bribery and anti-corruption· Anti-unfair competition
Snibe is committed to promoting long-term developmentthrough robust and standardized corporate governance.We continuously improve corporate governance, improveESG governance, integrate sustainable developmentstrategies into the Company's daily operations andmanagement, and actively communicate with stakeholdersto understand and respond to stakeholders' needs. Wecontinue to strengthen compliance management, build asound internal control system, carry out business activitiesin an honest and self-disciplined manner, and lay asolid foundation for the sustainable development of theCompany.
Major issues
Alignment with SustainableDevelopment Goals (SDGs)
REGULATINGCORPORATEGOVERNANCE
CORPORATE GOVERNANCE
Figure - Corporate governance structure
Corporate governance | ESG governance | Compliance in Operation
09/Environmental, Social and Governance (ESG) Report 2024/10Environmental, Social and Governance (ESG) Report 2024
Internal AuditDepartment
Board ofShareholdersBoard ofDirectors
StrategyCommittee
Remuneration andAssessment CommitteeNominationCommitteeAudit
Committee
Secretary of the Boardof Directors
Special Committees of theBoard of Directors
GeneralManagerGeneral Manager'sO?ceBoard O?ce
Anti-Bribery ComplianceLeading Group
Board of Supervisors
Composition of the Board of Directors and executive team
42.86%
42.86%
Board ofShareholders
Directors of theBoard of Directors
Proportion offemale directors
Meetings of theBoard of Directors
Non-independentdirector
Executives
Meetings of theBoard of Supervisors
Proportion ofindependentdirectors
Meetings of specialcommittees of theBoard of Directors
Independentdirector
Femaleexecutives
Meetings ofIndependentDirectors
Femaledirectors
Proportion offemale executives
timestimestimestimestimes
?Basic information about the Board of Directors and executive team
●Safeguarding shareholders' rights and interests
Information disclosure
Guided by investor needs and based on compliance, Snibe attaches great importance to information disclosure, discloses relevantinformation in a truthful, accurate, timely, fair, and complete manner in strict accordance with relevant laws and regulations, as wellas the requirements of the "Articles of Association", the "Information Disclosure Management System", etc., and actively ful?lls itsinformation disclosure obligations, and the Company designates "China Securities Journal", "Securities Times", "Shanghai SecuritiesNews", and "Securities Daily" as information disclosure newspapers and Juchao Information Network (www.cninfo.com.cn) as thewebsite for information disclosure, so as to ensure that the vast number of investors can obtain accurate information on an equalbasis and in a timely manner.In 2024, Snibe issued 98 announcements, including 4 periodic reports and 94 temporary announcements. In the 2023-2024 annualinformation disclosure appraisal for listed companies on the Shenzhen Stock Exchange, Snibe was awarded the highest grade of"A (Excellent)" for the third consecutive year. Snibe also won the "Golden Bull Award - 2023 Golden Information Disclosure Award"issued by China Securities Journal, re?ecting a high level of recognition of Snibe's information disclosure by the regulatory authoritiesand the capital market.
Diversification of the Board of Directors and executive teamThe Board of Directors of Snibe consists of 7 directors, including 3 independent directors and 3 female directors. Members of theBoard of Directors are highly experienced in ?elds such as biomedicine, ?nancial audit, risk control, and law, respectively.The executive team of Snibe consists of 6 executives, including 4 female executives. The team consists of professionals inbiomedicine, ?nance, marketing, clinical testing, etc. With a wealth of management experience, the team is able to capitalize onmarket opportunities and put into action e?ectively. The general manager and other executives are appointed or dismissed by theBoard of Directors. The general manager presides over the production and operation management of the Company, organizes theimplementation of the resolutions of the Board of Directors, and reports to the Board of Directors.The remuneration of directors and supervisors of Snibe is considered and approved by the shareholders' meeting. The remunerationand annual performance bonus of the Company's executives are directly linked to the Company's operating performance. TheRemuneration and Assessment Committee of the Board of Directors is responsible for the performance assessment of the executivesand the development of the remuneration plan, which is submitted to the Board of Directors for consideration and approval.
66.67%
the interests of all shareholders, especially small and medium shareholders. The directors of the Company, through continuousstudy, familiarization, and mastery of relevant laws and regulations, are committed to safeguarding the best interests of theCompany and all shareholders, and perform their duties in a faithful, honest, and diligent manner.The Board of Supervisors, in strict accordance with the requirements of the "Articles of Association" and the "Rules of Procedurefor the Board of Supervisors", supervise the major issues, associated transactions, financial status, and the legitimacy andcompliance of the directors and senior management of the Company in the performance of their duties, so as to e?ectivelysafeguard the rights and interests of shareholders, the Company's interests, and the legitimate rights and interests of itsemployees, and to supervise the Company's operation in compliance with the law.Three meetings held by the Company in 2024 were counted as follows:
Rao?WeiWeng?HemingRao?JieLi?XuWu?QianhuiZhang?MinZhi?YiDing?ChenliuLi?TinghuaLiu?HaiyanZhang?LeiYuan?Jinyun
MaleMaleFemaleMaleFemaleFemaleMaleFemaleFemaleFemaleFemaleMale
√√
√√√
√√
√√√
√
√
√
√
√√
Basic?salary?+?annual?performance?bonusNot?on?the?Company's?payrollBasic?salary?+?annual?performance?bonusNot?on?the?Company's?payrollFixed?allowance?for?independent?directorsFixed?allowance?for?independent?directorsFixed?allowance?for?independent?directorsBasic?salary?+?annual?performance?bonusBasic?salary?+?annual?performance?bonusBasic?salary?+?annual?performance?bonusBasic?salary?+?annual?performance?bonusBasic?salary?+?annual?performance?bonus
NamePositionAge
Expertise
Industryexperience
Risk?man-agement
Accou-nting
LawMarketing
Gender
Remunerationcomposition
Chairman?and?general?managerNon-independent?directorNon-independent?directorNon-independent?directorIndependent?directorIndependent?directorIndependent?directorDeputy?general?manager,?chief??nancial?o?cerDeputy?general?managerDeputy?general?managerDeputy?general?manager,?secretary?of?the?Board?of?DirectorsDeputy?general?manager
Corporate governance | ESG governance | Compliance in Operation
11/Environmental, Social and Governance (ESG) Report 2024/12Environmental, Social and Governance (ESG) Report 2024
Corporate governance | ESG governance | Compliance in Operation
Investor relationsSnibe attaches great importance to communication with investors and strictly follows relevant laws and regulations as well as the"Company's Investor Relations Management System". The chairman is responsible for leading investor relations management a?airs,the secretary of the Board of Directors is the person in charge of investor relations management a?airs, and the O?ce of the Boardof Directors is the functional department of the Company's investor relations management. In addition, we continue to learn fromexcellent investor relations management experience, constantly try to carry out investor relations management in a more e?ectiveway, and ensure that all shareholders have equal access to information by opening up diverse communication channels.In 2024, in order to strengthen the interaction with investors, we participated in the dedicated roadshow event for listed companiesin the pharmaceutical and biological sector organized by Shenzhen Stock Exchange with the theme of "New Opportunities forPharmaceutical and Biological Products", and actively responded to investors' concerns.In 2024, we issued 13 record sheets of investor relations activities, conducted regular brie?ngs on performance reporting, reverseroadshows, broker strategy meetings, etc., and organized more than 300 investor exchange activities of various types. In 2024, wewon the "Best Practices for Investor Relations Management of Listed Companies in 2023" award from the China Association of PublicCompanies for our outstanding performance. In addition, the Company's Secretary of the Board of Directors also won the "2024Shanghai Securities News Gold Quality Award - Excellent Board Secretary".
ESG GOVERNANCE
●ESG governance structure
A robust ESG management mechanism is pivotal for the top-down implementation of the company's sustainability strategy.According to relevant laws and regulations and the sustainable development governance requirements of listed companies, Snibecontinues to re?ne its ESG governance framework and optimize internal sustainable management.The Board of Directors serves as the supreme decision-making body for Snibe's ESG governance, and is responsible for leading andsupervising the Company's ESG initiatives, and reviewing and approving ESG-related planning, targets, and policies. Subordinateto the Board, the Strategy Committee is tasked with deliberating on ESG-related topics, reporting periodically to the Board on ESGperformance, providing guidance and recommendations for ESG implementation, and monitoring the execution of improvementplans.Under the Strategy Committee, there are the ESG Work Leading Group and the ESG Work Implementation Group. The ESG WorkLeading Group, composed of the general manager and deputy general manager of the Company, drives and monitors theimplementation of ESG programs while providing decision-support inputs to the Strategy Committee. The ESG Work ImplementationGroup is led by the O?ce of the Board of Directors, and the heads of various departments and subsidiaries serve as team membersand designated liaisons. This cross-functional team cooperates with various departments and subsidiaries of the Company toimplement ESG-related work, and summarize the progress and performance of ESG-related work.
●Communication with stakeholders
Snibe always values and maintains e?ective communication with stakeholders. We fully consider the impact of our own operationson all stakeholders, understand the opinions, suggestions, and expectations of stakeholders by establishing a regular communicationmechanism, and actively respond to the concerns of stakeholders, which serve as the basis for the Company's fulfillment of itsresponsibility for sustainable development.
Comply with national laws and regulationsImprove the compliance management systemEstablish an anti-commercial bribery systemStrictly control the product qualityCreate cooperation programs and platformsActively participate in government projectsRespond to government policiesCarry out charitable projectsImprove the corporate governance systemImprove the compliance management systemEnhance risk management and controlFul?ll the obligation of information disclosureOrganize and participate in investor exchangesIncrease e?orts in R&D and innovationStrengthen intellectual property managementStrictly control the product qualityIncrease e?orts in R&D and innovationEnhance customer privacy managementMaintain compliance in marketingStrictly abide by business ethicsImprove the service qualityConduct customer satisfaction survey
Addressing Climate ChangeCompliance in OperationAnti-commercial bribery and anti-corruptionProduct safety and qualityIndustry exchange and cooperationCommunity commonwealCorporate governanceSustainable development managementCompliance in OperationInvestor relationsProduct R&D and innovationProduct safety and qualityIntellectual property protectionProduct safety and qualityProduct R&D and innovationInformation security and privacyprotectionResponsible MarketingAnti-unfair competitionCustomer Service Quality
Government andregulatory agencies
Shareholders andinvestors
Customers
StakeholderIssue of concernForm and manifestation of communication
Corporate governance | ESG governance | Compliance in Operation
13/Environmental, Social and Governance (ESG) Report 2024/14Environmental, Social and Governance (ESG) Report 2024
Corporate governance | ESG governance | Compliance in Operation
Impact?MaterialityHighMediumLow
Financial?MaterialityLowMediumHigh
●Communication with stakeholders
Snibe attaches great importance to and continuously improves the identi?cation, management and analysis of important issues,and takes the concerns of various stakeholders as an important consideration in formulating sustainable development strategies,so as to accurately and e?ectively respond to the issues of interest to stakeholders, thereby providing an important reference foridentifying and managing risks and opportunities. This year, we invited stakeholders to participate in the survey in the form of anonline questionnaire to understand their key concerns, covering all employees, customers, suppliers and partners, shareholders andanalysts, media, industry associations, governmental organizations, non-governmental organizations, etc. Guided by the "DoubleMateriality" principle, that is, "Financial Materiality" and "Impact Materiality", we systematically evaluated and prioritized these issues.Steps for assessing important issues
Matrix of importance issues
Based on stakeholder feedback, weranked the issue's materiality in termsof "?nancial materiality" and "impactmateriality".
Corporate governanceCompliance in operationSustainable development managementCommunication with stakeholdersInvestor relationsAnti-commercial bribery and anti-corruptionAnti-unfair competition
Product Safety and QualityProduct R&D and InnovationCompliance in OperationsCustomer Service QualityIntellectual Property ProtectionInformation Security and PrivacyProtectionAnti-Commercial Bribery and Anti-Corruption
Corporate GovernanceEmployee Rights and Bene?tsSustainable DevelopmentManagementEmployee Training andDevelopment
Occupational Health and Safety
Responsible MarketingAnti-unfair CompetitionSupply Chain ManagementIndustry Exchanges andCooperationInvestor RelationsEmissions and Waste ManagementDiversity and Equal EmploymentStakeholder CommunicationEnvironmental ManagementEqual Treatment of SMEs
Energy ManagementResource ManagementCommunity CommonwealBiodiversity ConservationAddressing Climate Change
Product R&D and innovationProduct safety and qualityIntellectual property protectionSupply Chain ManagementCustomer Service QualityResponsible MarketingInformation security and privacy protectionDiversity and equal employmentOccupational health and safetyEmployee Training and DevelopmentEmployee rights and bene?tsIndustry exchange and cooperationEqual treatment of SMEsCommunity commonweal
Addressing Climate ChangeEmissions and waste managementEnergy managementResource managementEnvironmental managementBiodiversity conservationFollowing the "Double Materiality" principle,we conducted the "Financial Materiality"and "Impact Materiality" assessmentsto determine the important issues andpriorities for the year.Impact Materiality assessment:
Stakeholders were surveyed viaquestionnaires, and the impact materialityof each issue was evaluated based on thesurvey results.Financial Materiality assessment: Internal?nance experts assessed the ?nancialmateriality of each issue in two dimensions.
Upon reviewing the Company's evaluationresults of important issues in 2023, withreference to the "Shenzhen Stock Exchange Self-Regulation Guidelines for Listed Companies No.17 - Sustainable Development Report (Trial)"(hereinafter referred to as the "Guidelines"), GRIStandards and other international standards,SDGs and outstanding practices in the industry,and in combination with the Company's businessgrowth and ESG practices, we identi?ed otherimportant issues on the 21 topics speci?ed in the"Guidelines", and updated the Company's 2024issue library after comprehensive evaluation.
Issue identification and updateInvestigation and evaluationResults analysis and issue ranking
Environmental categorySocial categoryGovernance category
Strictly control the product qualityStrengthen supplier quality managementOrganize supplier meetings and trainingEstablish an anti-commercial bribery systemStrengthen intellectual property managementOrganize employee care activitiesEstablish communication channels for employeesEmployees' Congress and Labor UnionProvide diverse training programsDevelop a transparent promotion policyImprove the employee salary management andperformance management systemEstablish the environmental and occupationalhealth and safety systemActively carry out industry exchangesCreate cooperation programs and platformsProvide practice and research basesStrictly control the product qualityStrictly control waste dischargesCreate cooperation programs and platformsCarry out charitable activitiesParticipate in volunteer serviceMaintain good communication with the media
Product Quality and SafetyChain ManagementAnti-commercial bribery and anti-corruptionEqual treatment of SMEsIntellectual property protectionDiversity and equal employmentEmployee rights and bene?tsEmployee training and developmentOccupational Health and Safety
Product R&D and innovationIndustry exchange and cooperationProduct safety and qualityEmissions and waste managementIndustry exchange and cooperationCommunity commonwealBiodiversity conservation
Suppliers andpartners
Employees
Industry associationsand professionalorganizationsCommunity andmedia
StakeholderIssue of concernForm and manifestation of communication
Corporate governance | ESG governance | Compliance in Operation
15/Environmental, Social and Governance (ESG) Report 2024/16Environmental, Social and Governance (ESG) Report 2024
Corporate governance | ESG governance | Compliance in Operation
●Risk management and control
Snibe has established an internal oversight system in accordance with the relevant national laws and regulations and the "Notice onStrengthening the Internal Control Construction of Listed Companies and Proposed Listed Enterprises and Promoting Internal ControlEvaluation and Audit", the "Basic Standards for Internal Control of Enterprises" promulgated by the Ministry of Finance, and the"Guidelines for Internal Control of Listed Companies" issued by Shenzhen Stock Exchange, and continuously optimizes the "Manualfor Internal Control Management" and the "Internal Audit Management System", providing guidance for internal audit supervision.The Company has established a sound internal control and risk management framework. The Audit Committee is set up under theBoard of Directors, which is responsible for the supervision, inspection and evaluation of the Company's internal control, ?nancialinformation and internal audit. Under the leadership of the Board of Directors and the Audit Committee of the Board of Directors, theCompany has established the Internal Audit Department, which is responsible for formulating and improving internal audit, internalcontrol and other internal management systems, performing comprehensive risk assessment and monitoring of various businessprocesses, independently conducting internal audit and routine audit of all business departments and subsidiaries of the Companyevery year, forming audit reports and rectification proposals on the risk matters identified through the audits, following up theimplementation of recti?cation proposals, assisting the audited departments or subsidiaries in improving relevant business systemsand risk management processes, strengthening the risk management capabilities of the departments, and e?ectively reducing therisks in the Company's operation.In 2024, the Internal Audit Department systematically restructured its audit activities by aligning with the Company's businesspriorities and categorizing audits into three core pillars: marketing, supply chain, and corporate functions. By assigning dedicatedauditors to focus on each pillar, the department has enhanced audit efficiency and ensured comprehensive and in-depth auditexecution. In addition, we have checked the industrial and commercial information of more than 2,700 cooperating distributors,suppliers and other business partners to determine whether there were abnormal risks in industrial and commercial registrationinformation, business licenses, etc., and carried out on-site visits to nearly 120 business partners throughout the year. During callinterviews and on-site visits, we collected opinions from business partners and publicized the Company's anti-bribery system.In order to strengthen risk management and control in the supply chain, the Internal Audit Department intensi?ed supplier on-siteaudits this year, covering di?erent types of materials purchased by the Company. The suppliers for evaluation were selected basedon the early-stage data analysis and risk screening. During on-site visits, auditors assessed the facility scale, operational soundness,etc. to detect and monitor hidden cooperation risks.
●Probity and self-discipline
Snibe strictly abides by laws and regulations such as the "Anti-Unfair Competition Law of the People's Republic of China", the "CriminalLaw of the People's Republic of China", and the "Interim Provisions on Prohibition of Commercial Bribery", adheres to the managementconcept of "compliance ?rst", bases on the development strategy of "steady operation", improves market competitiveness with self-developed products, participates in market competition in a compliant way, and implements the compliance culture of fairness,integrity, and "Do things right". We hold a "zero tolerance" attitude towards any form of bribery, and strictly prohibit any form ofbribery in public or private during the course of business. In 2024, no cases of fraud were found in the Company's internal audits, andno internal or external reports of corruption were received.
Anti-bribery compliance managementThe Company has established an anti-bribery compliance management system. In March 2024, the Company's anti-briberycompliance management system obtained the international standard ISO 37001 certi?cation. We have disclosed the "Snibe Anti-Bribery Compliance Policy" on the Company's o?cial website to clarify the Company's overall objectives, policies and requirementsfor anti-bribery compliance management. We have set up an Anti-Bribery Compliance Leading Group, and formulated andimplemented the "Anti-Bribery Compliance Management Handbook" as well as a series of compliance management norms andcontrol procedures to ensure the e?ective operation of the anti-bribery management system. The anti-bribery compliance team,composed of Internal Audit Department and internal auditors of various departments, undertakes anti-bribery compliance functions.
Build a corruption-free environment
In order to enhance the anti-bribery compliance awareness and ability of employees, we regularly conduct on-site anti-briberycompliance training for all employees, and provide special training to new employees, management, compliance team, personnelin important positions such as marketing, ?nance, procurement, and HR, as well as external business partners. We regularly provideemployees with publicity of anti-bribery laws and regulations, cases, and the Company's anti-bribery policies through the Company'so?cial website, internal mails, OA system, etc. As mandated by the "Employee Handbook", all employees are required to sign the"Letter of Commitment for Anti-Bribery Compliance" upon onboarding. Additionally, business partners must sign the "Letter ofCommitment for Business Ethics", "Anti-Commercial Bribery Agreement" or other equivalent anti-corruption documentation prior tocommencing collaboration with the Company.We advocate that our business partners join hands with us to maintain sufficient anti-bribery compliance communication andsharing, to jointly build an honest, transparent, and incorruptible anti-bribery compliant environment, and to share the value createdby compliant operation.In 2024, we conducted 19 anti-commercial bribery trainings for internal employees and business partners, with a total trainingduration of approximately 1,300 hours, and 100% of employees have received the anti-commercial bribery training and signed anti-commercial bribery commitments.
COMPLIANCE IN OPERATION
Three lines of defense for Snibe's anti-bribery management
Business units ofother functionaldepartments
Anti-briberycompliance leadinggroup
Internal audit
department
Consciousness & abilityimprovementIncorporation into processesBusiness & behavior compliance
Risk reporting & consultingRecti?cation & improvement
Risk assessmentRule & process formulationGuidance & training & publicity
Reporting & communicationContinuous supervision &recti?cation
Internal auditInvestigation of reports
The first line of
defense
The second lineof defense
The third line of
defense
General manager (management representative)
Board of directors
Corporate governance | ESG governance | Compliance in Operation
17/Environmental, Social and Governance (ESG) Report 2024/18Environmental, Social and Governance (ESG) Report 2024
Corporate governance | ESG governance | Compliance in Operation
Supervision and improvement
According to the "Control Procedure for Internal Audit", "Control Procedure for Corrective Action and Preventive Action" and othersystem and procedure documents, the Anti-Bribery Compliance Team has conducted continuous monitoring of the e?ectiveness ofthe design and implementation of the anti-bribery management system, and self-rectify the defects and de?ciencies. At the sametime, the Internal Audit Department will regularly conduct internal anti-bribery compliance audits according to the annual plan toidentify system defects and de?ciencies and urge the implementation of recti?cation. In February 2025, the Company completed theannual external review of the anti-bribery compliance management system, and we continuously optimized the system based onthe improvement recommendations identi?ed during the review to ensure the e?ectiveness of the system.For potential non-compliance identified throughreported clues or audit findings, the Internal AuditDepartment will conduct investigations accordingto relevant procedures and requirements, and makesuggestions on whether to take disciplinary measuresbased on the investigation results.
●●●●
Official website of the Company: https://www.snibe.com/(Supervision and Reporting Module)Address: Internal Audit Department, Snibe Building, No. 23Jinxiu East Road, Jinsha Community, Kengzi Street, PingshanDistrict, Shenzhen 518122Email: audit@snibe.cnTel.: +86-755-26706462
Reporting channels
Anti-commercial bribery training for employees
Information security management mode
Anti-commercial bribery training for agents
●Information security
Snibe strictly abides by the "Data Security Law of the People's Republic of China", the "Cybersecurity Law of the People's Republicof China", the "Administrative Measures for the Graded Protection of Information Security" and other national laws, regulationsand industry norms, fully assumes the responsibilities for information security entities, and continuously deepens the constructionof information security systems. In 2024, the Company reported no information security incidents and no leakage of customer,employee and business partner information.Information security management
The Company attaches great importance to information security management, continuously deepens the construction of informationsecurity management system, and strengthens its own risk management and control capabilities. We have kept improving internalmanagement measures such as the "Information Security Management System" and "Communication Security ManagementSpeci?cation", and further standardized the information security management system and management processes to ensure thatall work is orderly organized and evidence-based. In 2024, the Company successfully passed the annual external review of ISO27001 Information Security Management System Certi?cation, and the remote service system Snibe Link won the "Level III of NationalInformation Security Level Protection" certi?cation. Both the resource allocation and management processes have been optimized.
Control and preventive measuresThrough the combination of institutionalized management and normalized inspection, the Company has improved its informationsecurity protection capabilities.In terms of proactive management, the Company applies technical means such as data loss prevention (DLP) system and ESM storagemedium management module to secure data. Leveraging a Situation Awareness platform, we conduct system penetration testingand bastion host audits to preemptively identify and mitigate potential cyber threats. In terms of wireless access authentication,internal employees access the wireless network through domain account authentication, and visitors access the wireless networkthrough SMS veri?cation code authentication to ensure secure wireless network access.In terms of reactive management, the Company comprehensively upgrades the terminal protection software, implements thenetwork access authentication mechanism, introduces the anti-tampering backup system, and optimizes the network partitionaccess control policy to build a multi-layered and three-dimensional security and protection system. For the handling of emergencyincidents, the Company has developed an information security management mechanism and emergency plan to clearly de?ne theresponse mechanism and handling process and measures in case of emergency incidents.Furthermore, the Company places paramount importance on information security awareness initiatives, prioritizes employee securityawareness enhancement as a critical component of its cybersecurity strategy, and has carried out multi-dimensional and multi-tieredsecurity training programs. We not only organize information security training for new employees to instill proper information securitypractices from day one, but also carry out special information security training for all employees every year.
CybersecurityCommitteeExecutives andrelevant responsible
persons of theCompany
ExecutiveentityIT Department
Externalentity
Suppliers, etc.
Information security training
In 2024, the Company conducted organization-wide information security training through a blendedonline-offline approach, covering in-depth analysis ofinternal and external threats, case studies of typicalinformation security incidents, detailed explanation ofsecurity operation specifications and inter-departmentalcollaboration mechanisms in daily work, as well assimulated demonstration combined with actual remoteintrusion scenarios to vividly and intuitively demonstratesecurity risks. Through the training mode of "theoreticalexplanation + practical exercise", the security awareness,risk identification ability and emergency response levelof all employees have been significantly enhanced.
Corporate governance | ESG governance | Compliance in Operation
19/Environmental, Social and Governance (ESG) Report 2024/20Environmental, Social and Governance (ESG) Report 2024
Corporate governance | ESG governance | Compliance in Operation
Snibe has long held the spirit of "Quality is our life". Driven by thespirit, Snibe continues to optimize the quality management system,increase investment in R&D personnel and equipment, and enhanceproduct quality and supply chain safety. Snibe aims to provide moreaccurate and reliable testing products for clinical doctors and createvalue for human health through continuous innovation.
PRODUCT QUALITY AND SAFETY
Value-added?Activities
FeedProcess Relation Diagram of the Quality Management System of the Company
InputOutput
ManagementResponsibilitiesResourceManagement
Continuous?Improvement?of?Quality?Management?System
Customers?andRegulations?
Feedback
Require-ments
Product
Customers?andRegulations?
●Quality management system
Snibe has established the policy of "Quality is our life" and set strict quality objectives. Besides a systematic, documented, andwell-developed quality management system, an organizational structure with de?ned responsibilities has been in place toclarify control requirements for the quality management process. Snibe has also continued to optimize and improve the qualitymanagement system, gaining recognition of its product quality management capability from stakeholders and ensuring stableproduct quality and safety amidst rapid business development.Quality Assurance Department, Key Reagent Material QC Department, Material Inspection Department, Reagent QC Department,Instrument QC Department, Component Inspection Department, etc. have been set up to ensure product quality throughout thelifecycle. While strictly abiding by external policies such as the "Quality Management System Requirements", "Medical Devices -Quality Management Systems - Requirements for Regulatory Purposes", and "Good Manufacturing Practice for Medical Devices",Snibe has formulated and implemented such internal management systems as the "Quality Manual" and "Control Procedurefor Product Monitoring and Measurement" that encompass the quality management process, speci?cations for products andequipment use, etc., to realize quality manufacturing.
· Product safety and quality· Product R&D and innovation· Intellectual property protection· Supply Chain Management· Responsible Marketing· Customer Service Quality· Equal treatment of SMEs
Major issues
STRICTLYCONTROLLINGTHE QUALITY OFPRODUCTS ANDSERVICES
Alignment with SustainableDevelopment Goals (SDGs)
Product
Implementation
Measurement，Analysis, andImprovement
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
21/Environmental, Social and Governance (ESG) Report 2024/22Environmental, Social and Governance (ESG) Report 2024
Adverse event trainingIn Mar. 2024, we conducted training on Chinese medicaldevice adverse events for the domestic technicalservice team, with 295 online participants. This trainingeffectively enhanced the ability of technical serviceprofessionals to investigate and handle adverseevents, and encouraged participants to continue topay attention to post-marketing product feedback,thus helping the Company to continuously improve itsproducts.
Quality Management System Documentation Structure
QualityManual(Policy & Objective)
Procedural documents
ExternalDocuments
Quality documents & technical documents(including systems, regulations,specifications, and DMR)Quality record(including DHR'S, QSR)
Quality Management System
Guidelines
Describe the operatingprocedures of each process
Describe the speci?c operation
of each element
Quality Management System
operational evidence
With the continuous growth of the global medical device trade business, in order to meet the regulatory requirements of variouscountries, Snibe has incorporated MDSAP requirements of ?ve countries (United States, Brazil, Canada, Australia, and Japan) into thequality management framework, and obtained the MDSAP certi?cate in Feb. 2024, further improving its quality management system.To align with the Company's global expansion, during the reporting period, we enhanced our Quality Management System (QMS) byfully integrating multi-regulatory compliance requirements, building on the foundation of MDSAP regulatory alignment. This initiativeculminated in the development of a comprehensive "Quality Internal Audit Compliance Manual", which standardized internal auditprotocols and ensured systematic and e?cient internal audits.
Internal audit of quality management system
The e?ective operation of the quality management system is not possible without a well-developed internal quality managementteam. Snibe has set up internal audit groups according to the "Control Procedure for Internal Audit", and appointed quali?ed groupmembers. Internal auditors receive expertise and skill training on quality management system standards and regulations, andinternal audit skills and methods. Moreover, they are assessed to ensure that each can accurately pinpoint and identify nonconformitiesor defects in the system.The Company conducts annual internal audits covering the entire product line to ensure compliance with ISO9001, ISO13485, IVDR,Good Manufacturing Practice. For this reason, the Company's management system is e?ectively implemented and maintained, andcontinuously improved.To strengthen the Company's quality management capabilities and promote the strict implementation of the relevant requirementsof the quality management system, in 2024, the Quality Assurance Department conducted a total of 28 training sessions on qualitymanagement, covering various aspects such as medical device regulations, document control, design changes, hazardous chemicalsmanagement, equipment management, risk management, and post-market surveillance. The trainees included relevant personnelof R&D, production, inspection, marketing, quality management, and other departments.To improve the knowledge reserve of personnel in the Quality Assurance Department and continuously deepen the professionalskills training, 136 in-department training sessions were completed throughout the year, totaling about 780 hours, focusing on IVDsupervision and upper-level laws and regulations (such as unannounced inspection, supervision and penalties), product registration,and post-market surveillance (including advertising compliance, adverse event reporting, recall procedures, sampling inspection,and regulatory penalties).Through the above training sessions, the expertise, skill pro?ciency, compliance awareness and risk prevention ability of the qualitymanagement personnel have been improved, providing a solid quality management team for the Company's development.
Quality management system certi?cation obtained:
ISO 9001ISO 13485MDSAP
Quality ManagementSystem Certi?cation
Medical Device QualityManagement SystemCerti?cation
Quality Management SystemCerti?cation
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
23/Environmental, Social and Governance (ESG) Report 2024/24Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
●National?Health?Commission?EQA?Pass?Rate?????????????●Domestic?Routine?EQAS?Pass?Rate202220232024
98.8%98.9%
99.7%100%100%100%
102.0%
100.0%
98.0%
96.0%
94.0%
92.0%
90.0%
E?ective operation and continuous optimization of quality management system
Snibe conducts comprehensive and independent evaluation through supervision and review by external auditors, and continues tooptimize the quality management system based on the assessment and on-site inspection results.In 2024, the Company underwent 14 quality management system audits from Guangdong Medical Product Administration, RussianFederal Service for Surveillance in Healthcare and other government regulatory agencies, T?V and other external audit institutions,including 8 audits by third-party certi?cation agencies, 5 audits on Good Manufacturing Practice for Medical Devices, and 1 audit onGood Distribution Practice for Medical Devices, covering all ?nal product manufacturing sites' QMS certi?cations, achieving a 100%audit pass rate.In 2024, a total of 29 products of the Company were subject to sampling inspection by government regulatory authorities, and thepass rate was 100%.Through internal and external audits to continuously track the operation of the quality management system, the Company's qualitymanagement system has achieved continuous optimization and quality management capabilities have been continuously improved,ensuring the high quality output of products.
Quality improvement of reference measurement laboratorySnibe has built a professional quality management system for the reference measurement laboratory in accordance with theinternational standards of ISO/ IEC 17025 and ISO 15195, passed the review by the China National Accreditation Service forConformity Assessment (CNAS) and obtained the accreditation certi?cate. Besides, high-end measurement devices and advancedreference materials at home and abroad have been introduced, and reference methods issued by the Joint Committee for Traceabilityin Laboratory Medicine (JCTLM) and national authorities have been adopted to ensure the metrological traceability of testing results.We work to build kit testing capacity for the reference measurement laboratory and establish a registered internal testing platform instrict accordance with national/industry standards, supporting product quality inspection.While playing an active role in the cooperative development of reference methods and the collaborative assignment of referencematerials, Snibe has been a stakeholder member of the Joint Committee for Traceability in Laboratory Medicine (JCTLM) anda corporate communication member of committees and working groups of the International Federation of Clinical Chemistryand Laboratory Medicine (IFCC), such as the Clinical Laboratory Management (C-TLM), the Standardization of Thyroid FunctionTests (C-STFT), the Bone Metabolism (C-BM), the Apolipoproteins by Mass Spectrometry (WG-APO MS), and the Commutability inMetrological Traceability (WG-CMT), driving the standardization and harmonization of related projects. Participating in cooperativeresearch on reference systems at home and abroad and strengthening peer exchanges will help improve the accuracy andcomparability of test results.By the end of 2024, Snibe has established more than 20 reference measurement procedures for vitamins, drug monitoring,thyroid hormones, non-peptide hormones, enzymes, etc. Among them, 9 procedures have been approved by the China NationalAccreditation Service for Conformity Assessment (CNAS), including 7 for enzymes, 1 for 17-hydroxyprogesterone, and 1 for25-hydroxyvitamin D3. Among them, three procedures for enzymes (ALT, CK, α-AMY) have been included in the JCTLM referencemeasurement service list database. In 2024, the EQA results for the reference measurement laboratory were announced, and Snibeachieved excellent results in 13 IFCC-RELA programs and 19 NCCL-EQARL programs applied, with a satisfactory pass rate.In 2024, the Company's reference measurement laboratory passed a routine supervision review by the CNAS regulatory authority.
●Product quality and safety management
External quality assessmentExternal quality assessment (EQA) is a system for checking, supervising, and verifying the laboratory's performance in order tomaintain a high standard of practice, and EQA results are largely dictated by the samples provided by the laboratory. To ensure thehigh-level performance of end users, we encourage EQA participation by domestic and overseas end users, which in turn allows usto follow up on product quality, safety, and performance.In the domestic market, Snibe participated in 41 EQA programs organized by the National Health Commission in 2024, involving 186items for evaluation, and we have achieved a 100% pass rate in routine EQA for three consecutive years. By the end of 2024, all theregistered chemiluminescence reagent projects approved by the National Health Commission have been involved in EQA programs.
In overseas markets, 89 products demonstrated exceptional performance in the EQA programs conducted by leading internationalaccreditation bodies in 2024, including Bio-Rad EQAS, RIQAS, RCPA-QAP, CAP, RfB, UK NEQAS, DEQAS, IFCC, NGSP, etc., which alsovalidated the reliability of the Company's products.In 2024, Snibe participated in the 25 Hydroxyvitamin D (25-OH Vit D) DEQAS and obtained the 2024-2025 Certi?cate of Pro?ciency. Wealso participated in the certi?cation programs for glycated hemoglobin by IFCC and NGSP, achieved excellent results and obtainedrelevant certi?cates.
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
25/Environmental, Social and Governance (ESG) Report 2024/26Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
ReportFollow-up
Report to or notifythe authorizedrepresentativesunder local adverseevent regulations
Adverse eventsupportingreportCollectInvestigate, Analyze
& Evaluate?
● Investigate
?
● Analysis of
causes?
● Relevance
evaluation?
● Risk assessment
?
● Measure
formulation
Methods
●Regulator systems or
notices?
● Feedback and
complaints
● Clinical experience
● Academic literature
● Others
Adverse eventinvestigation report
Response to adverse events
Improved product quality management capabilitiesTo elevate our product quality management level, Snibe made a lot of e?orts to improve internal quality control in 2024.
Product label and traceability management
In accordance with the "Control Procedure for Identification and Traceability", the Company has taken measures to preventidenti?cation mix-ups and misuse throughout the process of product implementation. We have established a unique device identi?er(UDI) for all medical devices we sold to ensure their traceability.Adverse events and product recallsTo guide, organize, and manage adverse event monitoring for medical devices, the general manager is in charge of overall controland resource coordination. At the same time, we have set up a steering group that brings together different departments, anddeveloped the "Control Procedure for Adverse Event" and supporting procedures and documents to collect feedback on adverseevents from medical institutions, businesses, regulatory authorities, and other relevant parties in a timely manner. In the domesticmarket, the Technical Service Department is responsible for adverse event investigation, cause analysis, and solution, and the QualityAssurance Department organizes relevant departments for risk assessment, and reports the adverse events with assessments inthe National Adverse Event Monitoring System within the speci?ed time limit. In 2024, we continued to collect, investigate, analyze,and evaluate adverse events, and con?rmed that there was no substantial injury, serious injury, or death caused by product defects.The investigation report has been uploaded and approved in the National Adverse Event Monitoring System. We have completed
the "Domestic Periodic Risk Assessment Report" and risk-return evaluation of products, and found no unacceptable risks in themonitoring process. The report has been submitted to the National Adverse Event Monitoring System in accordance with regulatoryrequirements.
In addition, the Company relies on the after-sales service stations in various regions to ensure timely response within 24 hoursafter receiving customer complaints, provide perfect after-sales service, and quickly solve customer problems. Information such ascustomer hotline, email, and fax is provided on product labels and the o?cial website of the Company to ensure that customers havesu?cient channels to complain and inquire about product problems.The Company has established the "Control Procedure for Recall of Medical Devices", which is cross-linked with complaints, adverseevents, and post-market supervision. At the same time, we timely analyze, investigate, and evaluate the collected information toensure that a recall is readily initiated according to regional laws and regulations.During the reporting period, the Company further optimized and upgraded the "Control procedure for feedback and complainthandling", specifying the critical workflow milestones in feedback and complaint handling, and the categories of feedbackinformation, so as to guide regional professional engineers to investigate, analyze, and follow up on feedback and complaints inaccordance with the requirements of the procedure document. In 2024, 100% of complaints received have been addressed.In 2024, Snibe had no product recall and received no regulatory warning or punishment on our product or service quality.
We have optimized more than 200 validation protocols to provide guidance for the validation personnel, so as to improve thetimeliness and accuracy of the Company's facility and equipment validation.The Company has paid close attention to the changes in post-market surveillance regulations and standards in various regions,and optimized the "Control Procedure for Adverse Event", "Control Procedure for Recall of Medical Devices", "Control andManagement Regulations for Vigilance System" and "EU Regulations on the Management of Adverse Events in PerformanceStudies".Improvement of cybersecurity in information transmission: Based on the requirements of China, Europe, the United States andother regulatory standards, Snibe has established the "Regulations on Cybersecurity Management", focusing on cybersecuritythroughout the product life cycle and improvement of product data in availability, con?dentiality and integrity.Instruments' Classi?ed Protection Level 3 Certi?cation: We have carried out the 2024 annual classi?ed protection evaluation forSnibelinker and iXLAB intelligent laboratory system in accordance with the regulations, achieving a "Good" evaluation result.
UMK International ConferenceAt the 2024 UMK International Conference in Poland, theCompany reported to experts in the field of metrologicaltraceability on the significance and challenges ofestablishing reference measurement laboratories inIVD enterprises, and demonstrated the work results ofour reference laboratories to attract more attention toreference measurement laboratories.
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
27/Environmental, Social and Governance (ESG) Report 2024/28Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
●Ever-improving R&D and innovation system
Instrument R&D platformThe Company has built and kept optimizing the product lifecycle management platform in line with its own characteristics. Throughstandardization, process, and data-based management, we have improved the reliability, predictability, and compliance of R&Dprojects, enabling product development more robust and efficient. After years of practice and iteration, our R&D managementplatform has become increasingly mature, providing strong support for product innovation, quality improvement and marketcompetitiveness, so that the Company can continuously launch high-quality products that meet customer needs and marketexpectations.
●R&D and innovation capability
After more than 20 years of hard work, Snibe has built a mature R&D system that spans the entire industry chain. There are fourtechnology platforms targeting the R&D of magnetic microspheres, automatic diagnostic instruments, diagnostic reagents, andkey reagent materials.Reagent R&D platformSnibe takes chemiluminescence immunoassay as the core business. After nearly 20 years of continuous innovation andaccumulation, we have mastered the core technologies such as antigen-antibody labeling technology, magnetic sphere-antigen/antibody coupling technology, and chemiluminescence starter preparation technology, and achieved revolutionary technologicalbreakthroughs in the ?eld of small molecules. The Company has established a complete reagent development platform, coveringimmunodiagnostics, biochemical diagnostics, immunochromatography, molecular diagnostics, coagulation and other IVD areas.
Innovation is our lifeblood and core competitiveness. Snibeworks to improve our R&D capabilities through continuous R&Dprocess optimization so that we can create more innovativequality products, continue to develop a whole product lineup, andconstantly create value for human health.
FOCUSING ON R&D AND INNOVATION
We have built an e?cient data managementarchitecture to achieve centralized storage,intelligent association, and dynamic updatesthroughout the product lifecycle. Our businessteams can work together based on the singlesource of truth to ensure information integrityand accuracy and reduce redundancy andcommunication costs. At the same time,data traceability and version managementcapabilities of the platform have beenoptimized, which allows the e?cient reuseof research and development results, andfacilitates knowledge accumulation andinnovation breakthroughs.
We have implemented robustprocess controls acrosscritical product lifecyclephases, covering productde?nition, engineering change,version management, etc.,to ensure the transparency,standardization andtraceability of the processes atall stages, e?ectively reducedevelopment risks, and shortenthe product launch cycle.
Supported by the R&Dmanagement platform,we can systematicallymanage product quality,including design veri?cation,engineering changetracking, and quality systemcompliance, to ensure thatproducts meet industryregulations and highstandards, and further improveproduct stability and safety.
Intelligent data management to improveR&D collaboration efficiency
Systematic process control toimprove project execution
End-to-end quality controlfor product excellence
Guided by GB∕T 42061-2022 IDT ISO13485:2016 "Medical Devices - Quality Management Systems - Requirements for RegulatoryPurposes" and the actual situation of the Company, the Reagent R&D Department has formulated the "Control Procedure for Designand Development" to define requirements for every phase of new product design and development. Additionally, department-speci?c processes and standards have been developed and continuously optimized for critical design and development stages,including the commercial demonstration and project initiation planning process for reagent products, the process ?nalization andvalidation protocol for reagent products, the R&D-to-production transition process for reagent products, and the design changecontrol process for reagent products, to standardize the management of new product development process.Given the large number of projects and abundant information in the rapidly-changing IVD reagent market, it is important to identifykey customer needs. We need to do the right thing in the business environment. To better serve the market with precise provisionof necessary products, our reagent R&D team adheres to the strategies of "market-oriented product development" and "lifecyclebusiness demonstration", and establishes a decision support mechanism for project initiation. In this way, we can determine whethera project meets market demand and is available for initiation and delivery.The business demonstration process is shown below:
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
29/Environmental, Social and Governance (ESG) Report 2024/30Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
Age distributionof R&D personnel
Educationalbackgrounddistribution ofR&D personnel
Under 30 years old
79.31%
30-40
19.38%
Over years old
1.31%
Bachelor's degreeor below
54.78%
Master's degree
44.50%
Doctor's degree
0.72%
Over 30 years of technology
accumulationProprietary magneticmicrosphere preparation
technologyOne of the few manufacturerswith such an advanced R&Dplatform in the industry
Recombinant protein expressionAntibody preparationProtein and small moleculemodi?cationPrimer and probe synthesisReagents for chemiluminescenceimmunoassay, biochemicalanalysis, nucleic acid analysis, andcoagulation analysisCNAS-accredited referencelaboratoryStakeholder Member of the JointCommittee for Traceability inLaboratory Medicine
Microelectronics R&DSoftware R&DMechanical design and
manufacturing
MagneticmicrospheresR&D technical
platform
IVDinstrumentR&D technical
platform
Key reagentmaterial R&D
technicalplatform
IVD reagent
R&DTechnicalplatform
R&Dplatform
R&D investment and team building
Snibe has maintained friendly exchanges and communication with key universities and developed long-term on-campusrecruiting plans to ensure a steady stream of talents. At the same time, Snibe has been recruiting social talents and independentlytraining R&D professionals and persons in charge. By far, it has built an efficient and high-quality team that identifies withcorporate culture.By the end of 2024, we have engaged 836 R&D professionals, an increase of 20.63% year-on-year, accounting for 29.42% of thetotal number of employees. Among them, 98.68% are aged 40 or below, and 45.22% have a master's or doctor's degree. A youngand high-quality R&D team is contributing to our R&D and innovation.
In 2024, our R&D investment was 453.59Million RMB, a year-on-year increase of 23.92%, accounting for 10% of our revenue.
R&D capability enhancement
●Improvement of instrument R&D capabilities
The research and development of IVD instruments is a highly integrated work, covering electronics, mechanical engineering,software engineering and many other fields. We are committed to building an industry-leading R&D system, continuouslyimproving our core competitiveness, and developing more breakthrough IVD instrument products. To this end, we have madeconstant e?orts to deepen and improve our R&D capabilities in the following ?ve areas:
In order to drive breakthrough efficiency and quality enhancements of instrument R&D during the reporting period, our R&Dteam explored advanced technologies and scienti?c methods to incorporate innovative ideas into every development phase,and continuously optimized the design process to improve product quality and R&D efficiency. Looking ahead, the Companywill deepen its digital transformation, further enhance its R&D and innovation capabilities, and forge a more intelligent andsustainable R&D pathway to ensure continued technological and quality leadership.
Strengtheninginterdisciplinarycooperation andtechnology integrationBuilding a systematicintellectual propertymanagement system
Stimulating innovativethinking and cultivatingexploring spirit
Improving the incentivemechanism and creatinga culture of innovation
Increasing R&Dinvestment andconsolidating thetechnical foundation
We actively foster an open R&D ecosystem by establishing long-term cooperative relationswith universities and research institutions, driving the application-driven translation ofcutting-edge technologies. For example, we set up a postdoctoral innovation practice baseand bring experts from different disciplines into R&D projects. Through interdisciplinarycollaborative innovation, we continue to expand the boundaries of technology and acceleratethe implementation of new technologies in instrument research and development.We have established a complete intellectual property management and protection system,covering patent applications, technical con?dentiality, intellectual property risk managementand control. The Company has a dedicated intellectual property management team,responsible for the evaluation and protection of technological achievements, to ensure thatinnovative achievements are legally and e?ectively safeguarded. At the same time, throughregular training and internal publicity, we raise R&D personnel's awareness of intellectualproperty and promote the continuous generation of high-value patents and softwarecopyrights.We advocate an innovation-driven development model, and encourage R&D personnel tokeep an open mind and dare to challenge the traditional technology path. The Companyprovides su?cient experimental resources and exploration space for the R&D team, supportscutting-edge technology research and new product concept verification, and encouragescontinuous optimization of product design from experiment and iteration to promotetechnological breakthroughs.We have built a multi-level innovation incentive system, including project meritorious serviceaward, technology innovation award, patent incentive plan, promotion incentive mechanism,etc., to fully stimulate the creativity of the R&D team. Meanwhile, the Company advocatesa proactive and scienti?c R&D culture, and supports technology exploration and innovationexperiments within a reasonable range. Under a strict quality control system, we empowerthe R&D team to systematically advance product solutions through data analysis andexperimental veri?cation, and promote technological progress, while ensuring product safetyand reliability.We insist on large R&D investment, providing advanced equipment and perfect experimentalconditions for instrument R&D. In 2023, the Company completed the Phase III constructionof New Industries Biomedical R&D Building, creating a better office and experimentalenvironment for the R&D team. At the same time, the Company continued to introduceadvanced R&D equipment and test instruments, so as to further enhance the overall strengthof instrument R&D and industry competitiveness.
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
31/Environmental, Social and Governance (ESG) Report 2024/32Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
●Reagent R&D capability enhancement
In order to improve the reagent R&D e?ciency, the reagent R&D team of the Company has adopted a series of organizationalstructure adjustments, and re?ned the work of all R&D groups of the Reagent R&D Department. The project management group,process management group, and R&D certi?cation group have been combined into the R&D management group, improving theR&D team's management capabilities. At the same time, the responsibilities of medical science a?airs were transferred to theDomestic Marketing Department, which improved the synergy between R&D and the market.In terms of R&D personnel cultivation, the Reagent R&D Department has developed a systematic training plan for new employees.Professional skills training was provided to employees based on the needs of di?erent positions in the R&D department. In 2024,the Reagent R&D Department conducted a total of 201 training sessions, including project experience sharing, professional basicknowledge explanation, and the use of professional tools to help R&D personnel consolidate their theoretical foundation andmaster core operational skills, laying a solid foundation for R&D capability improvement.
●Improvement of R&D capabilities in key reagent materials
Through relentless technological innovation and product development, the Company has achieved groundbreakingadvancements in the ?eld of small molecules. The key reagent material R&D team has established the R&D platform for anti-neoepitop antibodies (antibodies that form new epitopes after the complexation of small molecule antigens with their speci?cantibodies). Such breakthrough has accelerated the development of the Company's small molecule immunization project. Theresult of small molecule sandwich assay is highly consistent with that of mass spectrometry, which well compensates for theshortcomings of the competition method. The registration of 12 small molecule dual-antibody sandwich assay reagents including
Digital review andvirtual design
Simulation analysisand Data-drivenoptimization
Widespread use of 3Dtechnology
E?cient collaborationand agile R&D
The digital design and review process was introduced, and 3D modeling technology wasused to build a virtual prototype in the early stage of product development to simulate thecollaborative work between modules, e?ectively reducing the number of physical proo?ngtrials.In the project review process, the virtual review method was fully utilized to analyze andvalidate the design scheme in multiple dimensions, identify potential risks in advance, andensure a scienti?c and reliable design.Through the simulation analysis method and the experimental data, the design scheme wasvalidated for multiple rounds to ensure that the product performance reached the designgoal.A knowledge base was established based on historical projects using empirical analysis anddata-driven optimization to provide reliable technical support and decision-making basis fornew product development.3D technology was widely used for product construction and assembly simulation, so as todetect potential design problems, avoid repeated modi?cations, and reduce resource waste.The precise reduction capability of 3D design has supported subsequent production processdevelopment and assembly scheme optimization to improve the overall manufacturinge?ciency and quality consistency.Iterative optimization was employed in the R&D process to provide rapid feedback andimprovement at each stage, shorten the product development cycle, and ensure the qualityand performance of the product meet the requirements.Through regular cross-department collaboration meetings and real-time data sharing, theteam has achieved e?cient collaboration among multiple disciplines and improved decision-making e?ciency in the design and development stage.
????????
●R&D and innovation results
With the original intention of "making medical examinations more affordable for the public", Snibe has pursued independentinnovation while developing our core business as a socially responsible employer. We work to create value for human health, thusmaking quality medical resources available to all.Instrument R&D resultsThanks to enhanced R&D e?orts, we have delivered a lineup of instruments and IT solutions with increased accuracy and e?ciency,providing reliable data for clinical diagnosis.
25-hydroxyvitamin D, aldosterone, estradiol, progesterone, testosterone, tacrolimus, vitamin B12, folic acid, free triiodothyronine,total triiodothyronine, free thyroxine, and total thyroxine has been completed.In terms of antibody preparation, the Company has established a single-B cell preparation technology platform to drive thehigh-quality development of rabbit monoclonal antibodies and other novel antibodies, thereby further improving reagentperformance, signi?cantly shortening the development cycle for primary antibodies in small molecule projects, and improvingthe overall quality of antibody development. During the reporting period, the Company realized the self-production of ironpowder, a key component of the magnetic sphere, which helped to control the quality of in-house iron powder and reduce theirbatch-to-batch variability. Thus, the supply problem of iron powder was solved, the cost of the kit was further reduced, and themarket competitiveness was improved. In addition, the Company has kept increasing investment in personnel and equipment forthe research and development of key reagent materials, so as to improve the R&D capabilities of key reagent materials.
Protein Puri?cation System Semi-automatic Magnetic Bead Puri?cation System
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
33/Environmental, Social and Governance (ESG) Report 2024/34Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
MAGLUMI X10Fully-Auto ChemiluminescenceImmunoassay AnalyzerMAGLUMI X10 is a new ?agship instrument of Snibe'simmunization product line, with a throughput of up to1,000 T/H, making it a pioneer in chemiluminescenceat this scale. It inherits and upgrades the core X-TECHtechnology, allowing customers to operate easily andsatisfying the various needs of clinical testing.
HEMOLUMI H6Automated Coagulation Analyzer
Using magnetic bead method, a golden standard forcoagulation testing, the analyzer boasts the advantagesof high test accuracy, strong anti-interference ability, andfast testing speed. The built-in sample inspection modulecan e?ectively reduce the possibility of misdiagnosis.The instrument can indicate the amount of consumablesand support continuous loading without shutdown. Itcan be directly connected to the system track to helpdepartments improve testing e?ciency.
Biossays C10Automatic Biochemistry Analyzer
Biossays C10 is suitable for large hospitals andlaboratories with high requirements for throughputand intelligence. A throughput of 2000 T/H is achieved.An intelligent reagent management system allows theautomatic and continuous loading of reagents withoutshutdown and the addition of electrolyte moduleswithout slowdown, which greatly reduces operatorworkload.
Molecision R8Automatic Nucleic Acid Detection and AnalysisSystemThe independently-developed automatic nucleic acid detectionand analysis system is a comprehensive anti-pollution systemdesigned by the zoning idea of molecular laboratory and it alsoincorporates features of tiered negative pressure and high-e?ciency ?ltration. Consumables and reagents are continuouslyloaded. Samples are loaded with caps, with results immediatelyavailable, and emergency needs are prioritized. This simpli?esanalyzer process of nucleic acid detection and improvesdepartmental e?ciency.
SATLARS T8Laboratory Automation System (module added)SATLARS T8 is an open automation system developed by Snibe with completely independent intellectual property rights. It fullyintegrates the ?ve modules of biochemistry, immunoassay, electrolyte, coagulation, and molecule. The whole process of sampleloading, transport, processing, testing, and storage is automated, greatly reducing manual intervention and improving testinge?ciency. The unique two-way four-track design makes sample scheduling more ?exible toward dynamic balance. Modulardesign and multi-type tracks can be adapted to di?erent laboratory spaces and meet di?erent testing requirements through?exible con?guration. Emergency priority and intelligent scheduling can greatly shorten the TAT of samples. A specialized dataprocessing and information management system can help departments realize better quality management.In 2024, the development and major software upgrades of theBulk Loading Module, the Sealer/Desealer Module,and the Cold Storage Module were completed.
iXLAB Intelligent Laboratory (module added)iXLAB is an IT solution developed for the daily work of medical laboratories. The platform includes four sections: intelligentinspection, intelligent quality control, intelligent management and intelligent scienti?c research. It can optimize the laboratoryinspection process in all aspects, improve the detection e?ciency and the laboratory management quality, and providee?cient scienti?c research tools for the laboratory.Molecision MP16M Fully Automated Methylated Nucleic Acid Extraction and Purification System
Molecision MP16M is a professional extraction and transformation equipment for early screening of methylation tumors. Itcan realize fully automated experimental process from extraction, transformation, puri?cation to product dispensing with oneclick, greatly reducing manual operations and improving experimental stability and consistency. The use of pre-packagedreagent cartridges, with a throughput of 1-16, allows for ?exible sampling. It supports the early screening and transformationexperiment of methylated tumors in a variety of sample types, automated quantitative analysis, and ?uorescence concentrationdetermination and dilution of extracted nucleic acids.
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
35/Environmental, Social and Governance (ESG) Report 2024/36Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
The SATLARS T8 Laboratory Automation System won the iFInternational Design Award "Oscars of Design". Such recognitionstands as a strong testament to the innovation capabilities of ourinstrument R&D team and the growing global influence of ourbrand. It is also the ?rst product to receive such award.
In?uenza A Virus IgM Antibody Test KitCoxsackie B Virus IgM Antibody Test kitNovel Coronavirus (2019-nCoV) Test kitIn?uenza B Virus IgM Antibody Test KitHuman Parain?uenza Virus IgM Antibody Test KitAdenovirus IgM Antibody Test KitLegionella Pneumophila IgM Antibody Test KitRespiratory Syncytial Virus IgM Antibody Test KitAnti-PM-Scl Antibody IgG Assay KitAnti-Ro-52 Antibody IgG Assay KitAnti-Nucleosome Antibody IgG Assay KitAnti-Cardiolipin Antibody Assay KitAnti-Cardiolipin Antibody IgA Assay KitAnti-β2 Glycoprotein 1 Antibody IgA Assay KitAnti-β2 Glycoprotein 1 Antibody Assay Kit
Fibrin(ogen) degradation products assay kit
Parathyroid Hormone Assay Kit
Leucine Aminopeptidase Assay KitAdenosine Deaminase Assay KitCalcium Assay KitComplement C3 Assay KitNovel Coronavirus 2019-nCoV Nucleic Acid Test Kit
ADAMTS13 ActivityADAMTS13 IgGNfLAnti-MPO IgGAnti-PR3 IgGAMA-M2 IgGAnti-Sp100 IgGAnti-Gp210 IgGAnti-PM-Scl IgG
Infectious diseases/chemiluminescencereagents
Autoimmuneantibodies/chemiluminescencereagents
Thrombosis/chemiluminescencereagentsBone metabolism/chemiluminescencereagentsLiver function/biochemical reagentsInorganic ion/biochemical reagentsImmuno/biochemicalreagentsNucleic acid detectionreagents
Thrombotic thrombocytopenic Purpura, TTPHuntington's Disease, HDANCA-associated vasculitisPrimary biliary cholangitis
Systemic Sclerosis
III
II
II
II
IIIIIIIII
Reagent type
Reagent type
Rare diseaseReagent name
Reagent name
Quantity ofregistered reagents
Quantity ofregistered reagents
Registrationcategory
Registrationcategory
Product
Reagent R&D results
During the reporting period, the Company completed the registration of 17 new chemiluminescence reagents, 4 biochemicalreagents, and 1 nucleic acid detection reagent, which enriched the Company's reagent tpyes in infectious diseases, autoimmunity,and thrombosis. The newly developed reagents are listed below:
Attention to rare diseasesSnibe focuses on the study of rare diseases. We actively develop relevant products so that the life and health of patients with rarediseases are guaranteed. In addition to the rare diseases previously disclosed, the rare diseases we are working on during thereporting period include:
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
37/Environmental, Social and Governance (ESG) Report 2024/38Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
Research and development of geriatric, pediatric, and maternal productsThe Company actively responds to the requirements of documents like the national "Healthy China 2030 Planning Outline", the "StateCouncil's Opinions on Implementing Healthy China Initiative", the "14th Five-Year Plan for National Health" and WHO initiatives topromote the research and development of geriatric, pediatric, and maternal diagnostic products.The Company has carried out the R&D of cerebrospinal ?uid and blood detection products related to Alzheimer's disease, helpingto comprehensively promote the prevention and control of dementia in the elderly. By the end of the reporting period, the processdevelopment of four chemiluminescence cerebrospinal ?uid test kits (Aβ1-40, Aβ1-42, p-Tau-181, and Total-Tau) for AD had been?nalized, and the blood test protocol was under process development.In 2024, China's State Council issued the "Several Measures on Accelerating the Improvement of the Fertility Support Policy Systemand Promoting the Construction of a Fertility-Friendly Society", which would implement in depth the Maternal and Infant SafetyPromotion Action Plan and the Birth Defects Prevention and Treatment Capacity Enhancement Program. Human parvovirus B19,a pathogen capable of maternal-fetal transmission, may compromise fetal development. In alignment with national policies, theCompany has accelerated the development of human parvovirus B19 antibody detection solutions and enhanced its comprehensiveand high-quality TORCH screening panels. By the end of the reporting period, the process development of the Human Parvovirus B19IgG Antibody Assay Kit has been completed and entered the registration and access stage. The process development of the HumanParvovirus B19 IgM Antibody Assay Kit is about to be completed.Facilitating early screening and diagnosis of diseasesGuided by China's policy of early diagnosis and treatment, the Company actively advances the development of early screening anddiagnostic products for cancer, aiming to promote its early screening, early diagnosis and early treatment and to reduce cancerincidence and mortality rates.As an important means of early cancer screening, DNA methylation detection has the advantages of precise lesion localization,early-stage detection, comprehensive detection, safety and convenience. Such technology is applicable to both general healthypopulations and high-risk groups of cancer. Beyond screening, DNA methylation detection can also be used to predict the prognosisof tumor patients, develop more scientifically optimized treatment plans for tumor patients, and realize the whole processmonitoring and early intervention of cancer.During the reporting period, the Company carried out the research and development of methylation instruments. By the end ofthe reporting period, the prototype development had been completed, facilitating early screening and early diagnosis of relateddiseases. At present, the Company has established a comprehensive solution covering colorectal cancer, gastric cancer, lung cancer,liver cancer, and cervical cancer to detect the methylation of specific genes in the population, including fecal samples, humanperipheral blood plasma, and cervical exfoliated cells, to assist clinicians in making diagnostic decisions for patients.Promoting access to quality medical resourcesThe Company has proactively responded to the inter-provincial alliance centralized procurement activities of chemiluminescenceimmunodiagnostic reagents and biochemical diagnostic reagents products in China. Our declared immunodiagnostic andbiochemical diagnostic products were successfully included in Group A, thereby enhancing the accessibility of Snibe's premiumproducts.In terms of instruments, the R&D team remains committed to promoting the wider use of high-performance medical devices indi?erent regions and medical institutions through innovative design, cost optimization, and e?cient R&D management. The speci?cactivities undertaken are as follows:
These e?orts not only improve the convenience and economy of medical devices, but also re?ect the Company's commitment tosocial responsibility. In the future, the Company's R&D department will continue to promote technological innovation and processoptimization, and remain committed to creating more high-quality and cost-effective medical devices, further improving theaccessibility of medical resources, and contributing to the sustainable development of the global medical industry.Green R&D
The Company's instrument R&D team integrates the green sustainability principle into full product lifecycle management, fromdesign, production to packaging, transportation and usage, aiming to minimize the environmental impact of each phase. Throughcontinuous innovation and practice, the Instrument R&D Department not only provides customers with e?cient and environmentallyfriendly products, but also demonstrates our social responsibility in the ?eld of green development.
Optimizing productdesign andenhancing userexperience
Green designto reduceoperating energyconsumptionUser-friendly interface: The user interface is designed to be more intuitive and easy to operate,featuring fewer operation steps and partially con?gured dual-screen operating system for complexclinical scenarios, to meet the multi-level requirements while taking into account the refinedoperation and convenient interaction.Intelligent interaction design: Introduction of sound prompts, pop-up box reminders and real-timemonitoring functions has lowered the learning threshold for device use, and users at di?erent levelscan easily grasp the operation of the device.Diversified product coverage: Based on the needs of different medical environments, devicesadapted to multiple scenarios are developed to meet the diversi?ed needs of di?erent terminals.
Low-energy consumption design: In the product design stage, the R&D team minimized the powerconsumption of the device by optimizing the circuit layout and using high-e?ciency components.Such design achieves efficient use of energy without compromising performance, and helpscustomers reduce carbon emissions while using the device.Recyclable and high-durability material applications: In product development, recyclableand durable materials are preferred to extend the service life of devices and reduce resourceconsumption.Modular and lightweight design: Through modular structure and lightweight design, materialconsumption is reduced, and product maintainability and upgradeability are improved, avoidingadditional resource consumption caused by device updates.???
???
Cost optimizationto improve productaccessibility
Supporting thedevelopment ofprimary care
Advancing healthequity and globalaccessibility
Efficient design and production processes: By optimizing production processes and resourceallocation, we have reduced the R&D and manufacturing costs, ensuring that high-qualitymedical devices can be put on the market at a more competitive price.Advantages of batch production and standardization: The R&D team promotes modularizationand standardization at the design stage, improving the manufacturability and productione?ciency of the devices, e?ectively controlling costs, and ensuring product quality consistency.Affordable maintenance costs: By using durable materials and efficient design, we havereduced the subsequent maintenance costs of devices, and further alleviated the burden ofmedical institutions.Efficient deployment and adaptive design: Through design optimization, the devices can beinstalled easily and efficiently in a variety of medical scenarios to meet the actual needs ofprimary medical institutions and resource-constrained regions.Energy-e?cient design: we focus on development of devices with low energy consumption andhigh durability to ensure their long-term and reliable operation in di?erent environments.Comprehensive support services: We have established a comprehensive technical support andafter-sales service system to provide rapid response and professional guarantee, so as to helpprimary medical institutions give full play to device e?ciency and improve the level of diagnosisand treatment.Inclusive device deployment: By introducing cost-e?ective medical devices, the Company hasfurther lowered the barrier to accessing high-quality medical resources in resource-limitedareas.Technology-driven healthcare equity: Through continuous technological innovation and productoptimization, the Company has effectively narrowed the disparities in healthcare resourcedistribution across regions, actively contributing to the advancement of global healthcareequity.
????????
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
39/Environmental, Social and Governance (ESG) Report 2024/40Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
●Intellectual property protection
Snibe strictly abides by and implements national and regional laws, regulations, and standards, such as the "Patent Law ofthe People's Republic of China" and "Trademark Law of the People's Republic of China", formulates the "Intellectual PropertyManagement Procedure", "Patent Management Procedure", "Trademark Management Procedure", "Works Management Procedure"and other management documents, and continuously improves the construction of intellectual property management system.We pay attention to intellectual property protection. With a dedicated team of professionals and a mature management system,we integrate intellectual property creation and protection into our R&D and innovation system to provide strong support andguarantee for our product R&D and technological innovation. Internally, the Intellectual Property Department adopts early warningfor project research, project initiation, R&D, and product launch to manage risks throughout the development process and protectour technological innovations. Externally, investment, ?nancing, and technological cooperation are conducted with an early warningmechanism to reduce potential risks. At the same time, we actively organize training sessions to help employees understandintellectual property compliance and obligations, and strengthen their awareness and professional competence in intellectualproperty protection.With the outstanding performance in the creation, application, protection and management of intellectual property rights, Snibewon the title of "National Intellectual Property Demonstration Enterprise" in 2023, fully demonstrating our benchmark status andexemplary role in the ?eld of intellectual property rights. In 2024, Snibe won the title of "National High-tech Enterprise".
62938886716955
Cumulative numberof patents ?led
Number of validpatents granted
Cumulative number oftrademarks registeredIncluding validinvention patents
Cumulative number ofsoftware copyrights
●Supplier management
Management systems such as the "Bidding Management System", the "Control Procedure for Procurement", the "Anti-Bribery ControlProcedure for Procurement Transactions", and the "Supplier HSF Management Regulations" have been formulated to systematicallysupervise and manage supplier development and admission, ordering, performance evaluation, re-evaluation, qualificationmanagement, and supplier elimination, forming closed-loop management to ensure the fair and effective operation of theprocurement supply chain.We continuously optimize supplier management. In 2024, as required by relevant systems, we conducted anti-commercial briberyinvestigation and annual review for our major business partners, with a coverage rate of 100%. Mandatory anti-bribery trainingsessions with competency assessments were implemented for suppliers, accompanied by the execution of "Letter of Commitmentfor Anti-Commercial Bribery" or "Anti-commercial Bribery Agreement". Additionally, we secured full execution of "Environmental andOccupational Health and Safety Policy Notice" across our partner network. We have also completed the "Supply Chain InformationSecurity Agreement" with major suppliers, and continuously optimized and strengthened the management of anti-commercialbribery, environmental and occupational health and safety, and information security for suppliers.In accordance with the "Control Procedure for Procurement", the Company conducts annual requalification audits for bothprobationary and approved suppliers. Suppliers not up to standards are included on the "List of Unquali?ed Suppliers" based on thetype of materials they supply. Recti?cation and guidance support are available to help them improve, thus enhancing the stabilityand improvement of the supplier quality, and eliminating the unquali?ed supplier.
A stable, safe, and quality supply chain provides an importantguarantee for us to o?er high-quality products all the time. Guidedby "The Bidding Law of the People's Republic of China" and otherrelevant laws and regulations, Snibe has developed a soundsupplier management system. In addition to the quality of productsand services, the Company also pays attention to the managementof suppliers in terms of business ethics, environmental awareness,occupational health and safety, and continues to convey theconcept of sustainable development to suppliers to ensure thequality and sustainability of suppliers.
SUPPLY CHAIN MANAGEMENTGreen productionto reduceenvironmentalpollutionGreen packaging forsustainable logistics
Green use topromote low-carbonmedical careGreen developmentachievements andcommitments
Clean production process: Green manufacturing technology is used to optimize the productionprocess, reduce energy consumption and waste emissions, and ensure that the productionprocess conforms to environmental standards.Green supply chain: We cooperate with upstream suppliers to introduce environmentallyfriendly raw materials, promote the construction of a green supply chain system, and reduce theenvironmental impact of production phases.Wood-free paper and environmentally friendly materials: The R&D team fully adopts paperpackaging materials and recyclable eco-friendly materials in new products, reducing thereliance on traditional plastics and wood, and minimizing resource consumption.Lightweight packaging design: Through packaging structure optimization and thin materialadoption, the packaging weight is signi?cantly reduced, thereby reducing energy consumptionand carbon emissions in the transportation sector.International environmental standards: Our packaging materials strictly comply withinternational environmental standards to provide customers with green packaging solutions.Smart energy technology: We have developed more efficient operation modes, such asautomatic standby and dynamic energy consumption adjustment, to help users save energyduring long-term use.Recycling support for users: We provide customers with device upgrade support, reduce wastegeneration through resource recycling, and promote the green transformation of the medicalindustry.Green product coverage: We have completed the green upgrade of several products, includinglow-power design, green packaging and eco-friendly material applications.Carbon emission reduction: Our low-power technology and green design have significantlyreduced carbon emissions for customers.Sustainable development commitment: In the future, the Company will further increaseinvestment in green innovation, explore the application of more environmental protectiontechnologies and materials, and comprehensively promote the green development of themedical device industry.
??????????
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
41/Environmental, Social and Governance (ESG) Report 2024/42Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
Supplier admissionSupplier re-evaluationSupplier eliminationPreliminary investigationProduction and R&D capabilitiesQuality assurance abilityIntellectual Property RightsEnvironmental health and safetySocial responsibility and ethicalstandardsSample validationEnquiry and quotationOn-site certi?cation and reviewAnti-commercial BriberyInvestigation
Supplier classi?cationmanagementSupplier quali?cationmanagementRisk management of supplierOrganizational StructurePrice levelProduction CapacityQuality assurance abilityEnvironmental riskassessmentAnti-commercial BriberyInvestigation
Supplier monitoringEliminating abnormalsuppliers···········
··········
●Supplier communication
Technical exchange is an important measure to ensure product quality. In 2024, we organized nearly 260 online and o?ine meetingsto analyze quality problems and risks among suppliers, discuss corrective and preventive measures, solve existing problems, andprevent potential problems and risks.In the on-site audit stage before the new supplier was admitted, the Procurement Department would jointly conduct on-site visitsand exchanges with the personnel of relevant upstream and downstream departments such as R&D and quality inspection. Basedon the annual evaluation results of suppliers and the problems found in their daily management process, we would formulate anannual visit plan or arrange an unannounced audit, timely discuss with suppliers about the quality and sustainable developmentissues found in the audit, and discontinue the supply from suppliers to be recti?ed to mitigate supply risk. In 2024, we conducted atotal of 19 pre-admission and annual on-site audits.
●Sustainable supply chain management
To ensure the quality and supply safety of important materials, Snibe divides suppliers into three categories of A, B, and C bythe importance of supplied materials management to the product. Suppliers are reviewed and evaluated with category-speci?cindicators and standards based on the types of their materials and the nature of business. Category A suppliers are required toestablish a sound quality management system and sign a quality assurance agreement.After years of technology accumulation, we have established a well-developed supply chain risk management system. On the onehand, we enhance the safety inventory management of core components and include more alternative suppliers. On the other hand,we join hands with domestic manufacturers to develop and apply for major special projects of Shenzhen to promote the R&D andsubstitution of domestic core components. For key components, Snibe and suppliers need to work closely on all-round materialrecognition to fully guarantee the safety of materials. For some key materials, Snibe has formulated Plan B to deal with suddenrisks in the supply chain. For materials with a large amount of consumption, we usually purchase them from two or three suppliersat the same time to avoid the situation that the production of products is a?ected by the shortage of materials. Amidst the push toreplace foreign goods with domestic alternatives in the manufacturing industry, Snibe has opted for more domestic materials afterveri?cation, consolidating supply chain security. Furthermore, the strong reagent material R&D team serves as a solid backbone toguarantee the stable supply of raw materials for our reagent products. At present, most of the Company's key reagent materialshave achieved self-su?ciency, e?ectively reducing the risk of limited raw material procurement channels and ensuring the stabilityof the key reagent material supply.As for supply chain operation, the annual demand forecasting is updated on basis (2 + 3, short-term + long-term) so that bothsuppliers and Snibe can maintain dynamic safety inventory for quick response to ?exible demand.When selecting supply resources, we prioritize suppliers that are geographically close to us and have a relatively complete systemto ensure ?exible delivery and timely, e?ective communication and audit in quality control, as well as in-depth communication andcareful evaluation during R&D cooperation to guarantee stable supply after delivery.
●Responsible marketing management
Management systems such as "Control Procedure for Customer-Related Processes", "Regulations on the Management of DomesticDistributors", "Regulations on the Management of Overseas Distributors", "Regulations on the Management of Publicity Materials","Regulations on the Management of Intellectual Property Rights in Advertising and Exhibitions", "Regulations on the Managementof Intellectual Property Rights in Market Sales", and "Anti-Bribery Control Procedure for Distributors' Sales Business" have beenestablished to form a sound marketing management framework to ensure the protection of customer rights and interests andimprove customer satisfaction during the course of business.In both domestic and overseas markets, we adhere to the five principles of equality and mutual benefit, integrity and legalcompliance, win-win result and long-term cooperation, daily management with regular evaluation, and zero tolerance for bribery tomanage distributors.
95.90%4.1%By the end of 2024, the proportion of suppliers inChinese mainland was
and the proportion of suppliers in Hong Kong,Macao, Taiwan and overseas was
Snibe has always put the rights and interests of users first.Through strong brand building, and the domain-speci?c expertisecompetency enhancement of the marketing and after-sales servicepersonnel, the Company unswervingly implements responsiblemarketing, continuously elevates client service capabilities,empowers customers, and fosters industry exchanges andcooperation to expand the Company's leadership in the industry.
RESPONSIBLE MARKETING
Identificationof productrequirements
Review of
productrequirementsDetermination
of productrequirements
Implementationof bidding andcontract/order
After-sales
feedback
Communication with customers
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
43/Environmental, Social and Governance (ESG) Report 2024/44Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
As required by the "Regulations on the Management of Domestic Distributors", Snibe strictly abides by the "Anti-Unfair CompetitionLaw of the People's Republic of China" and the "Interim Provisions on Prohibition of Commercial Bribery". For brand buildingand market development, we have formulated the "Management System for Domestic Academic Conferences" to regulate theorganization of academic conferences and academic promotion. An internal CRM platform, which covers five modules of CRM,market management, product management, distributor management, and database, has been developed to help marketingpersonnel master information on customer relations, meeting procedures, product information, and online distributor management.This is how we realize responsible marketing.During the reporting period, the Company strengthened the management and control of the distributor's authorization. For example,the instrument number and other contents were included in the authorization document. The requirement for authorization timewas also added for the sale of instruments ready to enter the hospital to ensure the refined management of the distributor'sauthorization.In overseas markets, we follow the "Regulations on the Management of Overseas Distributors" under the ISO13485 framework, andrequire overseas distributors to conduct business as per local laws and regulations. To ensure global regulatory compliance of post-market products, the Company strictly abides by the regulatory requirements of various countries/regions for medical devices, andsets appropriate labels when selling products to ensure that the end users are fully aware of the product information. For example,for distributors in the EU, we adapt our products and business to the latest IVDR and transitional provisions, for example, adding theinformation of EU importers and updating compliance declaration.To safeguard the interests of distributors and end users, we proactively communicate with customers and end-user hospitalsregarding products undergoing phase-out or discontinuation, providing advance noti?cation of discontinuation timelines to establishtransition periods for users, while simultaneously o?ering optimized alternative solutions.
In terms of brand building in overseas markets, the Overseas Sales Department and Overseas Marketing Department have heldacademic exchanges such as Snibe Day to enhance the Company's international brand in?uence. In 2024, the Company conductedmore than 100 academic exchanges and conferences around the world through cooperation with IFCC and other leading industryassociations. The participants came to more than 20,000 person-times, mainly government representatives, hospital managers,doctors and experts from related ?elds, researchers, pharmaceutical companies, etc., covering laboratory terminals and customersin various regions around the world.Through the above academic exchange activities, we have built a platform for stakeholders in the industry to communicate witheach other, facilitated knowledge dissemination and opinion sharing, provided opportunities for cooperation in the industry, andestablished the brand and industry in?uence of Snibe.
●Responsible brand building
Brand control and supervision
During product marketing and promotion, the Marketing Department submits the new products and promotional materials (includingthe commissioned design of advertisements) to the Intellectual Property Department for review in strict accordance with therequirements speci?ed in the "Regulations on the Management of Intellectual Property Rights in Advertising and Exhibitions" andthe "Regulations on the Management of Intellectual Property Rights in Market Sales", so as to ensure compliance with the Company'srequirements for patent, trademark and copyright protection. At the same time, the Marketing Department is responsible for marketsupervision, risk control and prevention in the product release and publicity process.The Company also closely monitors the behaviors that damage our brand building, and clari?es the responsible departments andmeasures to deal with violations against our intellectual property rights to maintain Snibe's brand image.Brand buildingTo improve the brand recognition of our products, Snibe applied to the China Council for the Promotion of International Trade forbrand evaluation and certification of export commodities in 2024, and obtained the Certificate of Export Commodity Brand forboth "Snibe Biomedical" and "Snibe Diagnostic" brands. This certification enjoys extensive international recognition. It conductscomprehensive validation and attestation of export commodity brands across eight critical dimensions, including R&D innovationability, international certi?cation, market recognition, intellectual property protection, global operation, etc.The Company actively promotes the cross-departmental implementation of brand building, especially the frontline market divisions.During the reporting period, the Domestic Marketing Department launched a speech contest for product managers to help themquickly adapt to job requirements, improve professional knowledge and personal ability, and enhance the combat e?ectiveness.
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
45/Environmental, Social and Governance (ESG) Report 2024/46Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
Speech contest
International Symposium on Laboratory Medicine
"Tell Snibe's Stories" contest: In order to cultivate a high-caliber team capable of telling Snibe's stories withprecision, depth, and engagement, and solidify the "Snibe" brand among the population, the Companyorganized a contest with the theme of "Tell Snibe's Stories and Sustain Snibe's Excellence". Based on theselected scenario, participants made a simulation visit leveraging their work experience and professionalknowledge to tell customers the "Snibe's Stories" related to the brand, products, technology, value-addedservices, development history, and clinical research cases.
On Aug. 26, 2024, the International Symposium onLaboratory Medicine was held at the headquarters ofSnibe in Shenzhen. The conference was jointly organizedby the International Federation of Clinical Chemistry andLaboratory Medicine (IFCC) and invited 11 experts andover 150 participants.
●Responsible marketing training
The Marketing Department carries out targeted training for new employees, product managers, and marketing personnel to strictlyimplement responsible marketing. The training for new employees includes courses on product characteristics, communication skills,anti-bribery compliance management, etc. After such training, new employees can fully and accurately understand the advantagesof the product and thus provide professional solutions for customers.To improve the professional knowledge and personal ability of product managers and standardize their learning and assessment,the Company has formulated and issued the "Management Measures for the Professional Knowledge and Skills Assessment ofProduct Managers in the Domestic Market Department (Trial)", which has improved the advanced training participation rate andprofessional knowledge mastery of product managers.For marketing personnel, we have invited professional internal lecturers and senior sales colleagues to conduct training on productinformation and sales ability, so that sales personnel can better understand the product and its advantages, and provide professionalsolutions for customers. In 2024, the domestic marketing center conducted a one-week closed training on capacity improvement fornew sales personnel and regional managers, with trainees of 198 person-times and a training participation rate of 100%.
●Customer service management and capabilities
We practice the "service +" concept to continuously improve customer service experience, and provide carefree services forcustomers. We formulate and implement the "Control Procedure for Servicing Activities", "End Customer Management Measures" andother management systems to standardize the customer's consultation and complaint handling process. Through systematic trainingand professional guidance, we continuously strengthen the team's professional ability and service awareness, and optimize thequality of customer service.Snibe has built more service stations and upgraded on-site service. With 9 new service stations built in 2024, Snibe boasts a nationalnetwork of 170 service stations, which secures customer response in 1–2 hours. To help technical engineers in different regionssolve customer problems in a systematic way, we have developed the remote service system Snibe Link on our own to ensure acomprehensive and professional customer service.In overseas markets, Snibe implemented regional management with independent marketing, after-sales, market, and business foreach region. Product sales and after-sales personnel are better connected to improve the regional product and service performance.More foreign technical service personnel were recruited to ensure timely response to the urgent needs of distributors and endcustomers. As we expand our product lines, the number of overseas channels is also expanding in terms of both breadth and depthto bring quality products and services to more customers across the world. In major countries and markets, the Company strengthenslocalization through the establishment of overseas subsidiaries. Up to now, we have set up overseas branches in 14 countries. Byrecruiting local employees and applying for product circulation licenses, overseas subsidiaries boost localized operation for moremeticulous and comprehensive market coverage and premium service for end customers.
●Customer satisfaction
Snibe works to provide customers with professional products and services meticulously and timely. In case of any product problems,customers can get in touch with us through the "400" hotline, o?cial mail, and "External Information Feedback Form" on the o?cialwebsite. In addition, our technical service personnel strictly follow Snibe's "Control Procedure for Feedback and Complaint Handling"for closed-loop management through regular maintenance & customer visit and timely communication with customers. In 2024,100% of the complaints received have been handled, with a customer satisfaction rate of 100%.We regularly conduct customer satisfaction surveys to understand the opinions and suggestions of customers on the Company'sproducts and services. In 2024, the domestic and foreign customer satisfaction reached more than 98%.In addition, the Company actively participated in third-party research. For example, we participated in the "2024 China MedicalDevice Industry Data Survey" project organized by China Medical Devices magazine, which can fully re?ect the service evaluation ofdi?erent brands by medical institutions. In this survey, Snibe won the 2024 China Medical Device "National Brand Gold Award" and"Top Product Line" honors. We ranked ?rst in the comprehensive satisfaction, repurchase intention rate, net promoter score, trainingsystem satisfaction of the tertiary hospitals, re?ecting the customer's full recognition of our services.
With the core strategic concept of "customer-centric, market-oriented", Snibe keeps optimizing customer service solutions in allaspects by understanding customer needs, timely responding tocustomer complaints, providing professional and accurate services,and investigating customer satisfaction, so as to provide customerswith safe, reassuring, and innovative products and services.
CUSTOMER SERVICE QUALITY
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
47/Environmental, Social and Governance (ESG) Report 2024/48Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
IFCC Worldlab
On May 26-30, 2024, the 26th IFCC Worldlab was held inDubai, UAE. The congress was jointly organized by theInternational Union of Clinical Chemistry and LaboratoryMedicine (IFCC), the Arab Federation for Clinical Biology(AFCB) and the Saudi Society for Clinical Chemistry (SSCC),and sponsored by Snibe.
●Improving customer service capabilities
Snibe maintains proactive two-way communication through a customer-centric approach to deliver sustained customerempowerment. To help the medical laboratory departments establish a standardized quality management system and improve theaccuracy and mutual recognition of test results, we have provided ISO 15189 full-process support. On the one hand, we set up ISO15189 column through our WeChat o?cial account "Snibe IVD" to complete the online market education goal; on the other hand,we held ISO 15189 internal auditor o?ine training courses in Shenzhen, Changsha and other places to fully empower customersto apply for accreditation. During the daily service process, we discussed with the laboratory teachers the problems and questionsencountered in the validation analysis, so as to help them better understand the product, and master the product application andanalysis veri?cation methods.We attach great importance to the construction and training of technical service engineers. In 2024, we organized more than10 training sessions for domestic technical service engineers, and several exchange and learning activities for technical serviceengineers stationed abroad to comprehensively enhance their professional service capabilities. During the reporting period, weorganized 102 on-site training sessions for technical service engineers of overseas agents, with more than 460 person-times, and 109on-line training sessions. At the same time, through the "Snibe Forum" online platform, we delivered knowledge to technical serviceengineers of our agents to promote their understanding of the latest product-related information. On this platform, product-relatedinformation is constantly updated, and those engineers can learn to operate the product quickly.
49/Environmental, Social and Governance (ESG) Report 2024/50Environmental, Social and Governance (ESG) Report 2024
Product Quality and Safety | Focusing on R&D and Innovation | Supply Chain Management | Responsible Marketing | Customer Service Quality
· Addressing Climate Change· Emissions and waste management· Environmental management· Resource management· Energy management
Major issues
PROMOTINGGREENOPERATION
Alignment with SustainableDevelopment Goals (SDGs)
Snibe steadfastly implements sustainable developmentprinciples, rigorously enforcing the management standardsof environmental protection, conservation and productionsafety. We continuously strengthen environmentaland occupational health and safety management,systematically integrating the concept of green operationand safety in all aspects of daily operation. The Company iscommitted to ensuring the safety and health of employees,while creating an efficient and environmentally friendlyoperation model to promote the deep integration of greendevelopment and safe operation.
●Environmental and occupational health and safety management policy and objectives
Policy: Environment protection, health and safety, compliance with regulations, and sustainable development.Objectives:
(1) Zero fire incidents
(2) Zero chemical leaks and explosions
(3) Zero work-related fatalities or serious injuries
(4) Zero occupational diseases
●Environmental and occupational health and safety management initiatives
Employee safety and environmental protection constitute the cornerstone of our continuous and stable development. Snibehas always adhered to the policy of "Environment protection, health and safety, compliance with regulations, and sustainabledevelopment" to continuously strengthen the Company's overall safety and environmental protection construction. Snibe maintainsstrict adherence to laws and regulations like the "Labor Law of the People's Republic of China", the "Environmental Protection Law ofthe People's Republic of China", the "Safety Production Law of the People's Republic of China", the "Fire Control Law of the People'sRepublic of China", and the "Law of the People's Republic of China on Prevention and Control of Occupational Diseases", and hasdeveloped relevant supporting management systems according to those laws and regulations and internal management needs tocontinuously improve environmental and occupational health and safety management.In 2024, the Company invested 4.095 million yuan in environmental and occupational health and safety.
ENVIRONMENTAL AND OCCUPATIONAL HEALTH AND SAFETY MANAGEMENT
Waste:
We have established the "Wastewater, Emissions and Noise Management System" and the"Environmental Protection and Harmless Treatment System" to stipulate the management of various typesof waste generated during daily operations and production processes. They clarify the waste classi?cationand treatment methods, monitoring methods, etc., ensuring full compliance with environmentalregulations and e?ectively safeguarding the environment.Environmental protection and conservation:
We have formulated the "Resource and EnergyConsumption Control Management System" to regulate employees' practices in conserving water andelectricity. Awareness signage such as water and energy conservation reminders has been prominentlydisplayed to improve employees' awareness of energy saving and emission reduction. O?ce supplies aredistributed under a quota system to prevent overuse and waste. During product development, design,and production, we strictly adhere to relevant management requirements to minimize raw and auxiliarymaterial consumption, ensuring resource e?ciency and waste reduction.
EnvironmentalmanagementAreaInitiatives
Canteen:
All the canteen sta? are on duty with certi?cates, and we conduct regular inspectionsof food quality and hygiene management. The "Canteen Management System" has beenestablished to strengthen sanitation controls and ensure safety.Water for domestic use:
We have established the "Management System of Drinking Water forDomestic Use" to ensure that our drinking water meets the national requirements and protectsthe health of employees. We commission external agencies to conduct water quality testingbiannually. Water fountains are routinely inspected by third-party agencies. The internal tanksof water dispensers are cleaned quarterly. These measures ensure that the Company's domesticdrinking water fully complies with the national standards for drinking water quality.Occupational health:
We have formulated the "Management System for the Preventionand Control of Occupational Diseases", and have employees in high-risk positions signed the"Job-Specific Occupational Disease Hazards Notice" that clearly outlines job-related hazards.Necessary personal protective equipment is provided to all relevant staff. We conduct annualmonitoring of occupational hazard factors and organize pre-employment, in-service, and post-employment occupational health examinations. Employee occupational health records aresystematically maintained to timely identify and address occupational health issues.Work-related injury:
We have established the "Work-related Injury Management System"in accordance with the work-related injury insurance regulations and the actual managementrequirements to properly handle work-related accidents.We have developed emergency plans for production safety accidents, in which the protocols forhandling various emergencies such as ?res, hazardous chemical accidents, and object strikes areclarified. Regular emergency drills are conducted to ensure preparedness. A certified first-aidteam has been established, trained in basic life-saving techniques and trauma care. Each facilityis equipped with emergency medical devices and first-aid kits. These multi-layered measuresguarantee swift and effective responses to emergencies, minimizing risks and ensuring saferesolution.
Equipment:
We have formulated various safety operation procedures and safety managementsystems. All employees have received safety training before taking up their posts, and specialequipment and special operation personnel have been trained and certified by relevantdepartments at higher levels. Equipment and lines are regularly inspected.Hazardous chemicals:
We store and protect all kinds of chemicals, ?ammable, and explosivematerials according to their speci?c characteristic, ensuring categorized storage, clear labeling,and corresponding SDS attached. Designated personnel are responsible for managing anddocumenting chemical inventories, and ?re?ghting facilities and emergency response equipmentare deployed.Fire safety:
We have formulated safety systems such as "Fire Emergency Plan" and "EmergencyPreparedness and Response Control Procedures" to clearly define the responsibilities fororganizing and implementing daily fire safety management. Each region is equipped withcorresponding firefighting equipment and emergency exit indicators as required. Regularinspections of firefighting equipment and hazard checks are conducted, alongside company-wide ?re drills to ensure readiness. No major ?re-related incidents have occurred to date.
Healthmanagement
Emergencymanagement
Securitymanagement
AreaInitiatives
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
51/Environmental, Social and Governance (ESG) Report 2024/52Environmental, Social and Governance (ESG) Report 2024
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
Snibe recognizes that the physical impacts of global climate change and mitigation actions may pose significant risks orcreate opportunities for our business. During the reporting period, we identified relevant entity risks, transformation risksand opportunities based on the business development and operation of the Company, and formulated correspondingcountermeasures.
Snibe's greenhouse gas emissions predominantlystemmed from the utilization and consumptionof electricity, natural gas, gasoline, and diesel inour production and operations, direct emissionsresulting from the escape of refrigerants, andindirect emissions resulting from the consumptionof purchased electricity. During the reportingperiod, in order to more scientifically andaccurately calculate the Company's greenhousegas emissions, we commissioned SGS, aninternational authoritative certification body,to carry out a comprehensive and detailedgreenhouse gas veri?cation audit, and obtainedthe ISO 14064-1:2018 Greenhouse Gas Veri?cationStatement Certi?cate issued by SGS.
ADDRESSING CLIMATE CHANGE
Heavy rains,typhoons andother extremeweather occurfrequently orincrease inintensity
Energyprices riseas countriesrespondto climatechange
Investors areincreasinglyfocused oncorporateclimate actionClimatechange leadsto increaseddemand fornew products
Climate changepolicies promotetechnologicalupgrading ofenterprisesand increasebenefits
Snibe operates in a coastal city, whereincreased frequency or intensity ofextreme weather events, like heavy rainsand typhoons, may disrupt facility powersupply, leading to water/power outagesor damage to warehouses and equipment.Such risks threaten both property securityand our operational stability.
At present, Snibe's main energyconsumption relies on externally sourcedelectricity. Environmental protectionregulations are becoming increasinglystringent, with national and localgovernments rolling out policies to restrictcorporate carbon emissions. Rising fossilfuel prices have also driven up energy-related operational costs.Snibe recognizes that domestic andinternational investors prioritizetransparency in greenhouse gas (GHG)emissions and emission reduction targets.Failure to actively manage GHG emissionscould lead to ESG rating downgrade,negative publicity, reputational damage,and ultimately restricted financingchannels and higher capital costs.Global climate and environmental shifts,particularly rising temperatures, areincreasing the likelihood of infectiousdisease outbreaks and respiratoryhealth risks, which creates new productopportunities for IVD companies.
Reduced energy and resourceconsumption lowers both corporateemissions and operational costs. Byadopting more efficient productiontechnologies, the Company can increaseproduction capacity and revenue whileenhancing resource efficiency.
We actively monitor climate trends and havedeveloped an extreme weather emergencyresponse plan tailored to local conditions.We pay close attention to weather warninginformation, and implement the followingpreventive measures prior to forecastedextreme events: conduct safety inspections,clear drainage systems, repair roofs,reinforce perimeter walls, install waterbarriers, strengthen ventilation, enhancecircuit leakage protection, improvefirefighting capacity, etc.The Company has proactively implementedenergy management strategies, includingtechnology upgrades, source-level energyconsumption controls, intensified energyconservation and emission reductionpropaganda, etc. to reduce energyconsumption and carbon emissions.The Company has actively responded toinvestors' concerns, and voluntarily initiatedclimate risk identification, greenhousegas emission management and otherprograms for disclosure. Moving forward,the Company will further develop GHGreduction objectives in line with the needs ofenterprise development.Snibe is closely tracking diagnostic demandslinked to climate-sensitive diseases andproactively advancing R&D of targetedtesting products.
Through energy conservation andemission reduction initiatives, includingtechnological transformation andequipment upgrading, the Companycontinuously improves energyand resource utilization efficiency,achieving cost reduction and efficiencyenhancement.
Entity risk
Transform-ationalrisk
Opportunity
Type
Type
Influencing factors
Influencing factors
Specific impact
Specific impact
Countermeasures
Countermeasures
In 2024, the total carbon dioxide emissions (Scope 1 and Scope 2) resulting from the operations of Snibe amounted to15,352.44 tons of CO
equivalent. Among these, direct emissions (Scope 1) accounted for 1,138.78 tons of CO
equivalent, whileindirect emissions (Scope 2) stood at 14,213.66 tons of CO
equivalent. The carbon emission intensity was 0.0339 tons of CO
equivalent per 10,000 yuan
①。
① Direct emissions (Scope 1) encompass emissions directly generated by the Company through the consumption of fossil fuels, including gasoline, diesel, and natural
gas, as well as direct emissions resulting from escape of refrigerant. Indirect emissions (Scope 2) include emissions resulting from the consumption of purchasedelectricity by the Company. Total emissions represent the aggregate of direct and indirect emissions. The accounting methodology for electricity emission factors primarilyreferences the national average CO
emission factor for electricity outlined in the "Announcement on Release of 2022 CO
Emission Factor for Electricity", issued by theMinistry of Ecology and Environment of the People's Republic of China on Dec. 26, 2024. Additionally, calori?c value coe?cients and emission factors for other energysources are mainly derived from the "Guidelines for Compiling Provincial Greenhouse Gas Inventory" and the "General Rules for Calculation of the Comprehensive EnergyConsumption".
1,138.78Direct emissions (Scope 1) tons of CO
equivalent
15,352.44Total emissions of Scope 1and Scope 2 tons of CO
equivalent14,213.66Indirect emissions (Scope 2)
tons of CO
equivalent
0.0339
Carbon emission intensity
tons of CO
equivalent/10,000 RMB
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
53/Environmental, Social and Governance (ESG) Report 2024/54Environmental, Social and Governance (ESG) Report 2024
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
Rigorously adhering to the "Water Pollution Prevention and Control Law of the People's Republic of China", the "Law of thePeople's Republic of China on the Prevention and Control of Atmospheric Pollution", the "Law of the People's Republic of Chinaon the Prevention and Control of Environment Pollution Caused by Solid Wastes", the "Regulations on the Administration ofMedical Wastes" and other laws and regulations, the Company has formulated and revised management systems such asthe "Control Procedure for Issues", the "Resource and Energy Consumption Control Management System", the "Wastewater,Emissions and Noise Management System", and the "Hazardous Waste Management System", so as to effectively utilize
Bin classi?cation identi?cation
●Emissions and waste management
Wastewater managementAll sewage undergoes treatment following the principles of "rain and sewage diversion, collection at source, and reuse". Snibeimplements environmentally friendly sewage management practices. Wastewater is categorized into rainwater, domestic sewage,and production wastewater by source. Following a classified management approach, we collect each type of wastewateraccordingly. The sources of liquid medical waste and air ?ltration wastewater are collected and managed by accredited facilities.Meanwhile, the reject water without any chemical reagents and additives generated during the preparation of purified water isdirected to a dedicated reject water recovery pool for toilet ?ushing and park irrigation, and discharged from the municipal domesticwastewater pipe network into the Shatian Water Puri?cation Plant, contributing to resource conservation and waste reduction.Waste gas managementAll waste gases produced by the Company are subject to the principleof "classified collection, centralized treatment, and standards-compliantdischarge". The production waste gases are treated through the waste gastreatment facility to meet regulatory standards before discharge, with regularemissions testing conducted. Independent waste gas collection coversand fume hoods are installed in production workshops and locations orareas where waste gas is generated within each production line. The wastegas treatment device is equipped with activated carbon boxes and spraytowers to ensure that laboratory waste gas is discharged in compliance withenvironmental standards. The ?ow directions in waste gas collection pipelinesare clearly marked, and regular testing of waste gas by third-party institutionsensures alignment with relevant laws and regulations on emissions.Waste managementSnibe has established a dedicated task force for environmental pollutionprevention and control to perform classified management of medical andhazardous wastes. Medical wastes, including infectious waste, sharps waste,and chemical waste, are centrally collected in specialized medical waste bins,and then disposed of by accredited facilities. The ten types of hazardouswastes, including waste activated carbon, waste engine oil, waste lamp tubes,waste circuit board, waste thermometer, waste ink carbon ribbon, waste rust-proof oil, waste chemicals, waste packaging and air filtration wastewater,are centrally transported and disposed of by third-party organizations aftercollection.Solid wastes generated by the Company mainly consist of general solidwastes (domestic wastes), kitchen wastes, etc., all of which are entrusted toquali?ed third-party institutions for the transportation, utilization and disposalof solid waste, and the relevant qualifications and technical capabilities ofthe entrusted parties are reviewed. Office waste paper and cardboard aresorted and recycled by accredited facilities. To strengthen the standardizedmanagement of solid waste, the Company strictly implements garbageclassification. To enhance employees' awareness of garbage classification,facilitate employee identification, and reduce disposal errors, we haveoptimized the bin placement for general waste and food waste across allfloors, and updated the classification guidelines in the park to improveidenti?cation accuracy, and to foster a culture of environmental responsibility.
Snibe's carbon emission reduction target: To maintain a stable carbon emission intensity before the completion of Phase V ofthe R&D and production base, and to achieve a steady decline in carbon emission intensity after the completion of Phase Vand the normal operation of the R&D and production base. The main basis is that Phase IV of the R&D and production base willbe completed in 2025 and the base will then be put into use. With expanding business operations, electricity consumption isexpected to rise signi?cantly year-on-year, creating substantial short-term pressure on carbon intensity metrics.We continue to enhance energy e?ciency through technological advancements, equipment upgrades, and various measuresto maximize our energy utilization e?cacy. Key initiatives include:
GREEN OPERATION
●Conducting daily inspections and scheduled maintenance for generator sets, power supply and distribution
systems, and timely replacing aging components to ensure electrical safety.
●Installing a centralized control device at charging stations of the underground garages, which is intelligently linked
with the mobile phone to set a scheduled shutdown time, thereby effectively avoiding a potential safety hazardcaused by long-term standby charging of the vehicle.
●Deploying the time-controlled lighting system in the public areas of the park, such as the courtyard lights, parking
lot lights, and LOGO lights, through the mobile phone remote intelligent and accurate control of the lights in the park,e?ectively reducing energy consumption.
●Performing regular cleaning and maintenance of solar panels according to their usage to optimize heat conversion
e?ciency.
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
55/Environmental, Social and Governance (ESG) Report 2024/56Environmental, Social and Governance (ESG) Report 2024
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
The energy usage of Snibe in 2024 is detailed as follows:
26,480,307.55Purchased electricity
kWh
27.33
Gasoline
tons55,181Natural gas m
12.09
Diesel tons
resources and energy and strictly oversee the disposal process of hazardous wastes. The Company has not been listed as a keypollutant discharge entity by the environmental protection authority. In 2024, the Company did not violate any environmentallaw or regulation, and was not subject to administrative penalties by the environmental protection authority.
●Resource utilization management
Water resource management
We rigorously regulate water resource usage, increase the proportion of recycled water, and enhance water resource utilizatione?ciency through measures like water recycling and equipment adjustments.Reject water generated in the operation of the Company primarily results from the puri?ed water preparation process, and it meetsthe standards outlined in the "Reuse of Urban Recycling Water–Water Quality Standard for Urban Miscellaneous Use" (GB/T 18920-2020). Adhering to the principle of resource conservation and waste reduction, we've installed the water storage tank to recyclethe reject water and reduce tap water usage. Currently, we've established 100-cubic-meter and 180-cubic-meter reject waterstorage tanks for Phase II and Phase III parks of the Company, respectively, utilized for toilet ?ushing and park irrigation. In 2024, theCompany recovered approximately 20,870.1 cubic meters of reject water.The Company regularly maintains water conservancy facilities such as domestic water tanks and solar hot water systems, and timelyreplaces aging components to ensure water safety. A remote smart meter is installed on the master water meter to monitor thewater consumption in real time through the intelligent system, so as to avoid manual meter reading errors, quickly detect abnormalwater use, troubleshoot water leaks or equipment failures, and reduce water waste.We prioritize water balance testing as a cornerstone of water resources management, and conduct systematic testing, datacollection, and analysis to establish precise water usage equilibrium. By scrutinizing every aspect of water usage and optimizingprocesses with data-driven insights, we ensure stable operations while maximizing water e?ciency and conservation.In 2024, the Company's total water intake amounted to 244,266 cubic meters, with a water intake intensity of 0.5386 cubic meters per10,000 yuan, and 20,870.1 cubic meters of reject water recovered.
Material resource management
Snibe actively controls the rational use of energy and promotes the recycling of resources throughout R&D, production, andoperational processes. Various strategies are employed to optimize energy and resource management, strengthen the publicity andpractice of green concepts, and improve the rational use of energy and resource utilization e?ciency.The Company integrates the concept of energy conservation and environmental protection into daily operations. For example,employees are encouraged to use double-sided printing, save electricity, turn o? the lights, save water, actively report or repair waterleakage, etc. Air conditioning is mandated to no lower than 26 °C in summer and no higher than 20 °C in winter. Environmentalprotection signs are posted near the switch and the air conditioning panel to remind employees to save energy. In 2023, our canteenunderwent intelligent transformation, and adopted an intelligent plate mode, successfully reducing the reliance on disposabletableware.
244,266
Total water intake
m
0.5386
Water intake intensitym
/10,000 RMB
20,870.1
Volume of reject waterrecoveredm
57/Environmental, Social and Governance (ESG) Report 2024/58Environmental, Social and Governance (ESG) Report 2024
Environmental and occupational health and safety management | Addressing Climate Change | Green Operation
· Diversity and equal employment· Employee rights and bene?ts· Employee Training and Development· Occupational health and safety
Major issuesTALENTEMPOWERMENT
Alignment with SustainableDevelopment Goals (SDGs)
Talent is the core driving force for sustainable corporate development.Snibe prioritizes its talent strategy as fundamental to corporate growth.The Company advances the construction of employer brand andcomprehensively enhances the professional level of human resourcesmanagement. Embracing an open and inclusive philosophy, we haveestablished diversified talent recruitment mechanisms while protectingthe legitimate rights and interests of employees according to laws. Byestablishing a sound vocational training system and career developmentchannels, we create a fair and transparent career development platformfor employees and fully stimulate organizational innovation vitality. Wecontinue to improve occupational health and safety management, optimizethe welfare system, and better bind employees and bring them happiness,so as to achieve the common growth and value creation of enterprises andemployees.
●Diversity and equal employment
Equal employment
In strict accordance with laws and regulations such as the "Labor Law of the People's Republic of China" and "Labor Contract Law ofthe People's Republic of China", Snibe has formulated internal systems such as the "Human Resources Control Procedure", "EmployeeHandbook", "Employee Internal Transfer Management System", and "Intern Management System" to standardize the recruitmentand talent management process, and build a high-quality and diversi?ed talent team. It is clearly stated in the "Human ResourcesControl Procedure" that Snibe prohibits the employment of child labor, opposes discrimination in gender, health, and age, advocatesdiversity, and o?ers equal opportunities for every employee and job seeker. It is also explicitly speci?ed in the "Anti-Discriminationand Anti-Harassment Management System" that Snibe prohibits unfair treatment of employees in the process of recruitment, training,promotion, etc. on the basis of race, social class, nationality, religion, disability, gender, etc.In 2024, Snibe embraced a "hard worker focused" concept for exploration and practice in such fields as talent organization andmanagement, workplace environment, corporate culture, remuneration and welfare, and training system. We have shaped ourselvesinto a quality employer. This year, Snibe won honors like the HRoot Awards, "2024 Social Enterprise Excellence", "Most In?uentialEmployer 2025" by Haitou.cc, and "2024 Employer of Excellence in Occupational Credit" by Guangzhou Best Check Human ResourcesCo., Ltd.
Attraction and reserve of talentsSnibe values a well-layered talent pipeline by formulating comprehensive talent development strategies and exploring ?exible anddiverse ways to absorb talents. On-campus and o?-campus recruitment are two major ways Snibe brings in needed talents.For on-campus recruitment, we persist in working with universities on university-enterprise cooperation projects and ensuringongoing communication. At present, we have signed university-enterprise cooperation agreements with top domestic universitiesand built internship & practice bases. Nearly 900 faculty members and students have visited Snibe in the past year. By establishingjoint postgraduate bases and employment bases, as well as joint post-doctoral research bases and employment bases, and holdinglectures on career development in colleges and universities, we continue to deepen the university-enterprise cooperation, andhave established long-term cooperation with many colleges and universities to provide internship opportunities for their students.Currently, there are more than 200 interns in the Company. We provide one-on-one mentorship for interns who join early andprioritize full-time conversion opportunities for students who have excellent practice performance. These cooperation programsallow us to offer various practice and employment opportunities to university students and help them transform theoretical
Employee diversity
Snibe remains committed to building a workplace of diversity, equality, and tolerance. With a diversi?ed and inclusive recruitmentpolicy, we gather together top talents from across the world and encourage employees with di?erent backgrounds to give full playto their talents. We treat every employee equally and secure their rights and interests in recruitment, promotion, development,remuneration, and welfare regardless of gender, age, race, nationality, etc.We actively cultivate a diverse workforce and champion workplace inclusivity. We focus on empowering underrepresented groupsand providing employment opportunities for individuals with disabilities. To respect the religious and cultural di?erences of foreignemployees, we provide dedicated prayer rooms in the Company, and assist foreign employees in obtaining legal work permits andresidence permits to ensure their legal employment in China. We o?er re-employment opportunities for retired employees. Retireesare welcomed back and provided with competitive bene?ts while fully considering the operational needs.By the end of 2024, Snibe had 2,841 employees with 163 from minority groups, of which 36.43% were female, and 30.95% ofmanagerial positions were held by women.
ATTRACTION AND RETENTION OF TALENTS
knowledge into practical skills. In turn, this provides us with access to a huge talent pool.To recruit o?-campus talents, we not only work with mainstream recruitment platforms and experienced headhunting institutions athome and abroad, but also encourage our employees to recommend potential candidates. An array of talent introduction channelshelps to fuel our talent-driven development, foster a team of scarce cutting-edge talents, and integrate excellent talents to ful?ll ourstrategic goals.
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
59/Environmental, Social and Governance (ESG) Report 2024/60Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Employees by
gender
Employees byage
Employees byeducationalbackground
Management by
genderMale
63.57%
30 years old or below
62.44%
Associate's degree or below
27.49%
41–50 years old
4.05%
Master's degree
19.43%
Male
69.05%
Female
36.43%
31–40 years old
33.09%
Bachelor's degree
52.76%
Over 50 years old
0.42%
Doctor's degree
0.32%
Female
30.95%
●Employee rights and benets
Remuneration and incentives
Snibe keeps optimizing the remuneration system with a focus on both value and fairness to o?er competitive salaries for employees.We have in place a remuneration program that covers salary and diverse incentives, designed to reward and motivate core andoutstanding talents for their signi?cant contributions.
Welfare system
According to the national and local regulations, we ensure that our employees are entitled to statutory holidays and leaves, andwe contribute to social insurance and housing accumulation fund for all employees. For our female employees, we not only providepaid marriage leave, maternity leave, breastfeeding leave, and other holidays stipulated by national laws to female employees ofreproductive years, but also build baby care rooms for working mothers, o?er yoga classes, and hold Women's Day and Mother'sDay activities.We promote work-life balance and encourage employees to take necessary breaks. We foster a harmonious and healthy atmospherethrough regular annual meetings, traditional festivals, and team-building activities to better bind employees and bring themhappiness. The health of our employees, a top priority for us, is secured through regular occupational health examinations, lectureson traditional Chinese medicine and health, and free medical clinics.
●Employee care and communication
Employee activitiesSnibe cares about employees' life after work and o?ers a variety of cultural activities and holiday care activities. All employees areencouraged to participate in such activities. Employee activities include:
In addition to presenting honorableawards to teams and individualswith outstanding sales, R&D teamswith breakthroughs, and outstandingemployees, Snibe also rewardsemployees who devote themselves totheir work, boast remarkable abilities,and deliver superior results.
Holiday allowanceStaff quartersStaff canteenShuttle busAnnual lotteryCommemorative giftActivity fundsAssistance in employee's settlingdownSupplemental commercial insuranceOccupational health examinationHealth consultation hotlineHealth lectures and free medicalclinics
At every anniversary, employees with longservice will be honored for their long-termcontribution, and all employees will receivethe anniversary commemorative coins.
LibraryGymYoga classBasketball courtTeam-building activitiesFestival activitiesClub activitiesAmateur cultural activities
●●●●●●●●
●●●●●●●●●●●●
●●
●●●
Semi-annual and annualsalary adjustmentSalary adjustment for positionSalary adjustment for rank
Statutory holidaysStatutory leaves, including sickleave, work injury leave, marriageleave, funeral leave, maternity leave,paternity leave, breastfeeding leave,annual leave, etc.Social insurance, including pension,medical insurance, unemploymentinsurance, work-related injuryinsurance, maternity insurance, etc.Housing accumulation fundOther statutory benefits
Remuneration
Statutory Benefits
Honors
Employee Welfare
Long Service Award
Work-life Balance
By the end of 2024, we have signed labor contracts with and paid social insurance for 100% of our employees.
Lantern riddle guessing on Lantern Festival
Fun sports meeting
DIY activities on Women's Day
Talent competition
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
61/Environmental, Social and Governance (ESG) Report 2024/62Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Snibe organized online and offline activities during traditional holidays, annual celebrations, and annual meetings,such as lantern riddle guessing on Lantern Festival, gami?ed check-in challenge on Goddess Day, canvas bag DIY onMother's Day, fan making on Dragon Boat Festival, etc. On the Company's 29th anniversary, we hosted talent competition,fun sports competition, fun fair and other activities. Additionally, customized commemorative badges are designed asbirthday gifts for every employee. We have organized a welcome party for fresh graduates to help them better knoweach other and blend in with the big family of Snibe.To promote the inheritance of Snibe's culture and the realization of the strategy, and to commemorate the hard workand dedication of "Snibers", the Company has customized the corresponding service commemorative coins as a symbolof their growth and dedication at the milestones of each Sniber. This year, Snibe held the second CommemorativeCoin Awarding Ceremony for employees serving the company for 10 years and above. The ceremony showcased thevalues behind the service commemorative coin, that is "shouldering responsibilities, enjoying challenges, and pursuingexcellence". To foster a culture of relentless pursuit of excellence, the Company convened the 2024 Annual PerformanceReview & Honors Gala to formally recognize individuals and teams who delivered exceptional impact on mission-criticalinitiatives.To help employees relax and keep ?t, Snibe has built an in-house gym, a yoga room, a library, a basketball court, etc.,and employed external professional yoga teachers to regularly conduct yoga classes at the Company. In addition,football and badminton courts rented outside the Company are also available on a regular basis, providing a platform foremployees to keep ?t and enrich their spare time.
●
●
●
Employee communication
Keen to listen to employees' voices and learn their sense of happiness and ownership, Snibe keeps working to meet all employees'demands and expectations.For new employees to better understand and ?t into the park life, we presented the "Guide to Park Life" and explained it in person onthe day of employment to help them get familiar with the park and better blend in the Company to enhance their sense of ownershipquickly.To facilitate communication between employees and the management, Snibe builds feedback platforms of di?erent types at alllevels for equal, e?cient, and constructive communication within the Company.
We continue to optimize the Snibe Smart Park Online Platform, and encourageemployees to give feedback on the sta? canteen, equipment repair and various parkservices through the platform."The Snibers", an in-house magazine, serves as the main medium to promote corporateculture and highlight our employees. It includes such columns as company news,management policies, employees showcase, re?ections on work, the voice, and sparetime life, which focus on listening to employees and uniting all together.Every year, we would collect questions with shared attention for the general managerto answer at the annual meeting.Through our year-end performance appraisal process, we systematically gatherthe opinions or suggestions of all employees on all aspects of the Company'smanagement, and report them to the management, with designated departmentstasked with implementation and progress tracking.A dedicated feedback email and an anonymous submission portal are available foremployees to voice concerns or proposals. Management responses to substantivesuggestions will be fed back to the employees.Heads of each department stay informed of employees' demands through departmentmeetings and annual performance talks.The Human Resources Department regularly collects feedback and recommendationsfrom new employees and replies to them through symposiums and other forms. Wealso interview employees who intend to leave to improve the talent retention plan in atargeted manner.
Smart Park PlatformIn-house Publication
BOSS Q&AAnnual Feedback Collection
Dedicated Feedback Email andAnonymous Submission PortalDepartment MeetingsSymposium
Feedback PlatformFeedback and Communication Mechanism
9.56%
New Employees
In-house publication Questions for BOSS Q&A
Turnover Rate
①
①Turnover rate = annual employee departures/average annual headcount
"Snibe Cup" badminton friendly match"Snibe Cup" badminton friendly match
Employees' CongressThe labor union at Snibe forms a bridge of communication between the management and general employees. The Employees'Congress aims to protect the rights, interests, and welfare of employees and keep the company dynamic. The Labor Union regularlyholds the Employees' Congress as required and maintains close communication with all employees to get them involved in thedecision-making of important a?airs. Rules and regulations are also being optimized and improved to better safeguard the rightsand interests of employees. In 2024, Snibe held one Employees' Congress to re-elect the employee representative supervisor of theBoard of Supervisors, and to review and approve the "Employee Handbook", "Employee Transfer Management System" and othersystems.Talent introduction and retention for 2024:
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
63/Environmental, Social and Governance (ESG) Report 2024/64Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Commemorative coin awardingceremony
●Training system
Diverse training system
Snibe believes that employee training boosts the corporate development. On top of the "Training Management System", Snibe hasformulated a series of training management measures, detailed rules, and operational guidelines such as the "Operational Guidelinesfor the Implementation of Training Process" and the "Operational Measures for the Implementation of Training System" to supportand standardize training.We keep improving and optimizing various training systems and processes. Committed to "talents are the most important resourcesfor the company", we have put in place a training operation system that focuses on both "talent construction" and "productempowerment". A diverse training system of all layers and categories is being built, along with talent training mechanisms of alltypes, to fuel the internal business operation at all positions. A combination of both online and o?ine training, including onboarding,induction/transfer training, management external expert training, and special training programs for serving sta?, improves both thesoft and hard skills of employees and drives their career development to shape a talent pipeline for business development.In 2024, we o?ered 13,298 training opportunities of 86,482 hours for our employees.
●Employee ability improvement
All-round ability improvementWe have been developing and upgrading training courses that target and serve the company's development strategy and businessneeds.
●Cultivation of fresh graduates
We have established a training framework for fresh graduates, including three stages: "entry", "growth" and "success". Group trainingafter joining the company helps new employees to get the basics of the company, swiftly learn and adapt to the corporate culture,and complete the transformation from campus to workplace. Tutoring, job rotation, and panel discussions enable fresh graduates toquickly ?t into the team and master essential job skills. With the guidance of the direct supervisor and tutors, these new employeescan establish a solid groundwork for independently undertaking key tasks in the future.
●General knowledge and soft skills enhancement
Product basics popularization and work-related comprehensive soft skill enhancement are realized through Snibe Lecture with thehelp of an online learning platform "DingTalk". The continuous exploration and trial of the past three years helped clarify the positionand functions of Snibe Lecture. Popular courses such as reporting, year-end summary, weekly report, work plan, and "Four Hypers"(hypertension, hyperlipemia, hyperglycemia and hyperuricemia) medical courses have been established, further strengtheningthe internal influence and gaining good reputation. In 2024, Snibe Lecture presented 37 courses covering topics such as officesoftware, o?cial document writing, work reporting, and "Four Hypers" medical courses, with a total of about 3,500 participations vialivestream or playback.
●Improved management capabilities
To strengthen the reserve and development of mid-level and frontline managers, we not only engage managers from relevantdepartments at our Shenzhen headquarters but also organize intensive training sessions there for managers from domesticbranch o?ces. Furthermore, industry experts are invited to deliver targeted knowledge-sharing and foster in-depth discussions.
In 2024, we launched a Leadership training program for marketing teams at home and abroad, a special training program to buildhigh-performance IVD teams, a special training program for domestic technical service teams titled "Team Empowerment - WorkFacilitation, Communication and Coaching Motivation", an MTP manager training program for R&D teams, and a special trainingprogram on e?cient communication and collaboration for production teams. Those special training programs helped break downinternal communication and management barriers, deepen understanding and collaboration across departments, functions, andpositions, and enhance team cohesion.
●Enhancement of professional skills
The Company's part-time internal trainer team has carried out many activities to meet the professional learning needs of employees,such as product optimization and upgrading training, performance verification training, new product internal launch meeting,and annual special training. What's more, we actively communicate with industry experts, suppliers and other partners, and hostactivities like "Clinical Testing Lecture ", "Snibe Day" and "Inspection Industry Experts/Specialized Exchange Meeting" to further meetthe learning needs of personnel in speci?c functions/positions for "advanced, specialized, cutting-edge" knowledge, and providesupport and momentum for internal technical reformation and product innovation.We provide employees with more opportunities and platforms for learning and growth by investing more and more in talentcultivation and integration. In 2023, we o?cially obtained the certi?cation as a "Shenzhen High-skilled Talents Training Base", whichserves as a promising platform with countless opportunities for employee and talent training next. In 2024, we won the award of"Shenzhen Top 10 Model Platforms for Lifelong Vocational Skills Training" from Human Resources and Social Security Bureau ofShenzhen Municipality.
EMPLOYEE TRAINING AND DEVELOPMENT
Schedule of Snibe Lecture
Shenzhen High-skilled Talents Training BaseShenzhen Top 10 Model Platforms for
Lifelong Vocational Skills Training
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
65/Environmental, Social and Governance (ESG) Report 2024/66Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Quali?cation and talent recognition
●Support for employee quali?cation
Snibe encourages and rewards all employees to take the exams for relevant skills certi?cates and gain post quali?cations by coveringall associated costs, including exam fees and annual reviews. Employees participating in off-job training can also get subsidiesof transportation, catering, etc. By the end of 2024, our employees held more than 400 skill certi?cates, including "Medical DeviceLaboratory Management and Inspection Operations", "Special Equipment Safety Management and Operation", and "Primary CareParamedic".
●Assistance in talent recognition and professional title application
We assist quali?ed employees in applying for high-level talent recognition and professional titles under the talent policies of localgovernments, and we encourage employees to further their professional competitiveness. We also hold skills festivals with Shenzhencolleges and universities to identify the ?eld-operational experts with excellent skills. In 2024, seven employees were recognizedby the Shenzhen Pingshan District Human Resources Bureau as the "Class B Leaders" (2 employees) and "Class C Leaders" (2employees), and 36 employees have applied for professional titles in their respective ?elds.
●Employee promotion and development
Diverse promotion and development pathsTo "make the best use of talents", we set up clear and detailed promotion channels for employees with a series of clear internalpromotion systems, including the "Rank Management Measures", "Rank Promotion Management Measures for Reagent R&DPersonnel", "Supplementary Rules for Promotion and Management of R&D Personnel", "Technical Grade Evaluation Measures forEngineers in Domestic and Foreign Technical Service Departments", "Rank Promotion Management Measures for Product Managersin Domestic Marketing Departments", etc. At the same time, the Rank Evaluation Committee, the highest authority for rank promotionand development, has been established to ensure fair, reasonable, scienti?c, and compliant selection.We set three career development paths of "expertise", "management" and "business" to provide fair and impartial career choices anddevelopment opportunities for all employees. We adopt the promotion method integrating "technical expertise" and "managementability". Employees with outstanding contributions or special talents are promoted more than one grade at a time, while employeeswith exceptional comprehensive and professional ability are promoted and cultivated, so as to guide employees to leverage theirown edges in enhancing professional skills and overall competitiveness. To facilitate the ?ow of talent, we look out for and properlysupport employees who intend to try other positions and encourage horizontal development.Snibe aspires to grow with employees together andset position requirements in line with the corporategoals and employee career goals. Clear, exact, andfair career paths have been designed for employeesof all ranks and all positions. We encourageemployees to leverage their talents and challengenew positions. Moreover, we continue to optimizethe talent management by adjusting the existingrank evaluation requirements, so that employees canhave a clearer understanding of their developmentdirection. The talent analysis report and humanresources management report of each center areregularly output, so as to timely identify and motivateemployees with outstanding work performance. Thisyear, we have launched the Top Ten New Employeesand the Individual Merit Award for the ?rst time.In 2024, 100% of employees received year-endperformance appraisals, and more than 100 employeesapplied for and completed internal transfer.
0601,773.04
Deaths fromoccupational injury
Occupational injuriesexcluding deaths andserious injuriesSerious injuries fromoccupational injury
Losses of working hoursdue to occupationalinjuries
hours
●Occupational health
Snibe believes in "people ?rst" in its management and always puts employee health in the ?rst place. Various measures are takento safeguard the physical and mental health of employees. The Company strictly abides by relevant laws and regulations onoccupational health and safety like the "Safety Production Law of the People's Republic of China", and the "Law of the People'sRepublic of China on the Prevention and Control of Occupational Diseases", and has developed management systems such as the"Control Procedure for Hazards", the "Management System for the Prevention and Control of Occupational Diseases", and the "Work-related Injury Management System" to identify, analyze and manage potential risks in daily operations and protect the health andsafety of employees.
OCCUPATIONAL HEALTH AND SAFETY
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
67/Environmental, Social and Governance (ESG) Report 2024/68Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Career paths for employees
Employee career development system
Employeecareerlevelappraisal
Careerdevelopmentpath/level/standard
Employeecareerdevelopmentplanning
Where am ICareer
development path
Where to go?How to go?
Deputy?general?
manager
Management path
Chief?engineer
Professionaltechnology path
Deputy?general?manager
of?marketing?center
Businesspath
Director/deputy?director
Sta??engineer
Regional?deputy?director/directorManager/deputy?
manager
Senior?engineerRegional?manager
Supervisor
Intermediate?engineer
Assistant/trainee
District?manager
Team?leader/specialistEngineer
New?employee
Sales?manager
Occupational disease prevention and controlSnibe continuously regulates occupational health monitoring to prevent occupational diseases. The Human Resources Departmentconducts statistical analysis and management of occupational hazards. During employee onboarding, the department truthfullyinforms employees about the occupational disease hazards associated with their positions, including potential consequences,protective measures, and relevant benefits. The Company implements occupational disease prevention measures and requiresemployees to sign the "Job-Speci?c Occupational Disease Hazards Notice".The Company sets up bulletin boards in prominent positions in the production workshops to issue rules and regulations on theprevention and control of occupational hazards, operating procedures, emergency rescue measures for occupational hazardsaccidents, and the detection and evaluation results of occupational hazards in the workplace. The Company organizes occupationalhealth examination for employees who are exposed to occupational disease hazards and special operations in strict accordance withthe relevant regulations based on the types of occupational disease hazards and the level of exposure. The physical examinationreport is added to personal health records, and the employee is informed of the actual results of occupational health examination.
Safeguarding physical and mental health
The physical and mental health of employees are of great importance to Snibe. To improve the food hygiene and safety level of thecanteen, the Company entrusts a quali?ed third-party agency to carry out standardized recti?cation of the canteen, including riskassessment, risk mitigation and on-site recti?cation. After the recti?cation, the canteen's food hygiene and safety level, operationmanagement ability, canteen image are signi?cantly improved.In addition, we work with commercial insurance providers, the Preventive Treatment Center of Shenzhen Traditional Chinese MedicineHospital, and the professional physician service team of China Information Association of Traditional Chinese Medicine to deliverhealth and wellness lectures, traditional Chinese medicine health consultation and testing services, and personalized insuranceservices for employees to protect their health.
Hazardous goods managementTo regulate the management and use of hazardous goods and safeguard employees' life and company property, we haveformulated the "Hazardous Goods Management System" to e?ectively manage and control the hazardous chemicals that employeesmay be exposed to, including highly toxic substances, in?ammable products, corrosive products, etc.We properly classify, store and protect various chemicals, ?ammable and explosive materials according to their speci?c characteristic.Hazardous chemical warehouses are equipped with adequate protective equipment, fire protection and emergency responsefacilities, and have obvious warning signs (smoking or open flames prohibited, danger of fire, danger of poisoning, warningcorrosion, wear protective gloves, wear gas masks, etc.). Hazardous chemicals are classified according to their characteristicsand SDS documents are stored in the corresponding hazardous chemical storage cabinet, which is managed and registered bydesignated personnel in accordance with the regulations. Hazardous goods are counted by warehouse keeper on a quarterly basis.In addition, we organize an emergency plan exercise for hazardous goods annually.
●Safe production
Security managementSnibe always regards safe production as the lifeline of enterprise development, and unswervingly implements the responsibilitysystem for safe production. To fortify safety safeguards, the Company conducts regular safety awareness campaigns and trainingprograms featuring diverse formats and substantive content. These initiatives systematically elevate employees' safety consciousnessthrough multi-dimensional and in-depth approaches, comprehensively enhance their occupational safety competencies, ande?ectively reduce various safety risks.In 2024, we organized induction safety training for new hires to help them develop a strong safety philosophy from the start. Weorganized a number of comprehensive emergency drills and special emergency drills. Comprehensive emergency drills includeemergency evacuations, demonstrations and drills on the correct use of ?re equipment, demonstrations and drills on the correctwearing of ?re escape masks, and demonstrations and drills on cardiopulmonary resuscitation. Special emergency drills includeelevator emergency drills, limited space drills, and ?re drills. Fire drills cover all employees, e?ectively improving the emergencyresponse capabilities and team collaboration capabilities of all employees. 73 employees participated in the first-aid trainingoutside the Company, and mastered basic ?rst-aid knowledge and skills, including: cardiopulmonary resuscitation (CPR), traumacare, emergency evacuation, etc. A ?rst-aid team was set up, and the Company's ability to respond to emergencies was enhanced,ensuring that timely help could be provided in emergency situations.In terms of the safety and security of the o?ce area, the Company strictly abides by the national regulations and standards to ensurethat the ?re passages in the o?ce area are unblocked, and standard ?re protection facilities and equipment are well equipped.Designated personnel is responsible for conducting regular inspections to eliminate potential safety hazards in a timely manner. Thesafety exits and evacuation routes in the o?ce area and production area are clearly identi?ed, and the person in charge of each ?oorand the evacuation guide are clari?ed to ensure that the personnel can be evacuated quickly and orderly in case of emergency. Wehave equipped the park with AEDs, one on the top ?oor of the high-rise building and the other on the front desk of the new building.Existing AEDs can basically cover all buildings of all heights to ensure proper emergency rescue capability.
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
69/Environmental, Social and Governance (ESG) Report 2024/70Environmental, Social and Governance (ESG) Report 2024
Attraction and Retention of Talents | Employee Training and Development | Occupational Health and Safety
Hazardous waste and chemical disposal exerciseIn May 2024, we conducted emergency response exercisefor hazardous wastes and chemical leakage at ourhazardous chemicals warehouse and hazardous wastetemporary storage room. The exercise included detailedexplanations of potential injuries caused by varioushazardous chemicals, their identification methods, andclassification labeling standards. Participants engagedin hands-on simulations of chemical leak containmentprocedures, with over 100 employees actively involved.This initiative achieved positive outcomes in enhancingworkforce competency in handling hazardous chemicals.
●Industry-University-Research collaboration and multi-center research
In active response to the "14th Five-Year Plan for Pharmaceutical Industry Development" and the "Healthy China 2030 PlanningOutline", Snibe has continuously focused on addressing the pain points and needs of front-line clinical and laboratory medicine, andattached great importance to industry-university-research-medical cooperation. Snibe has joined hands with universities, hospitals,and enterprises for all-round cooperation targeting disease diagnosis and treatment, medical technology development, IVD researchand development, technology commercialization, and talent training. By leveraging respective strengths, all parties aim to promoteproduct diversi?cation and technological innovation in IVD. Amidst the national endeavor to prevent and control the four major non-communicable diseases, Snibe has carried out relevant research with medical institutions to help early diagnosis and treatment ofchronic diseases.
INDUSTRY EXCHANGE AND COOPERATION
Industry exchange and cooperation | Community Commonweal
71/Environmental, Social and Governance (ESG) Report 2024/72Environmental, Social and Governance (ESG) Report 2024
· Industry exchange and cooperation· Community commonweal
Major issues
FULFILLINGSOCIALRESPONSIBILITY
Alignment with SustainableDevelopment Goals (SDGs)
While pursuing corporate development, Snibe has alwaysbeen committed to its social responsibility. Relying on ourcore competencies and technological expertise, we activelyparticipate in industry exchanges and cooperation, promotethe popularization of medical examination knowledge, andfacilitate the development of the industry. Through strategicpartnerships with leading healthcare institutions, we drivetranslational research to enable early diagnosis and treatmentof chronic diseases. We support scientific research andeducation by cultivating diagnostic talents, and acceleratingeducation and medical research.
Multi-center Research on Improvement of Hepatocellular Carcinoma ScreeningEfficacy Through Multiple Indices
Multi-center Research on Screening of Aldosterone and Renin in Patients withPrimary Aldosteronism, Establishment of Diagnostic Cut-off Values, and ClinicalApplication Evaluation
The project "Multi-center Research on Improvement ofHepatocellular Carcinoma Screening Efficacy Through MultipleIndices", led by Peking University, supported by the Company,and conducted across ten nationally renowned Grade A tertiaryhospitals, successfully concluded in Shenzhen on Aug. 4, 2024.Based on the big data from Chinese chronic hepatitis B population,this multi-center research has established the GADA model, anauxiliary diagnostic system for liver cancer, and the supportingGADA software for early screening of liver cancer. This model andsupporting software provide clinicians with an effective tool forearly diagnosis of liver cancer, and facilitate early screening anddiagnosis of liver cancer in clinical practice.
On Jan. 12, 2024, Snibe initiated a multi-center research on"screening of aldosterone and renin in patients with primaryaldosteronism, establishment of diagnostic cut-off values,and clinical application evaluation" in cooperation with 7clinical units, including Fuwai Hospital, Chinese Academyof Medical Sciences. The research aimed to establish a newstandard for the screening and diagnosis of aldosterone andrenin concentrations based on the chemiluminescence smallmolecule "sandwich method".
● Academic extension
Supporting the cause of chronic disease managementIn 2024, the Company conducted a number of chronic disease management activities, and the relevant conference convened expertsand scholars from the ?eld of laboratory medicine to discuss in depth the strategies, cutting-edge concepts, latest technologies andpractical challenges of disease prevention and treatment, aiming to promote the accurate diagnosis and clinical management ofchronic diseases and contribute to the high-quality development of chronic disease management in China.
Participating in the preparation of laboratory medicine booksAs the editor-in-chief, Snibe participated in the preparation of "Medical Laboratory Equipment and Application" (immunology section,biochemistry section, laboratory intelligence and informatization section) and "Expert Consensus on the Development and Evaluationof In Vitro Diagnostic Products" led by renowned experts in Chinese laboratory medicine, transforming our technical accumulation inchemiluminescence, biochemistry, automated assembly line, reagent research and development, laboratory intelligence constructionand other ?elds into standardization knowledge and consensus. These publications provide authoritative and practical guidance tofacilitate industry technology standardization and the development of China's medical industry.Supporting clinical academic researchIn 2024, more than 100 papers and academic posters incorporated Snibe MAGLUMI and Biossays products for clinical studies orproduct evaluations. The Company has established collaborative partnerships with leading international clinical research institutions,including the University Hospital of Liege, Belgium, and the Lille University Hospital, France, to advance clinical academic researcharound the world.
Publishing professional articles to popularize laboratory knowledge
In 2024, Snibe released 40 professional articles on its WeChat Official Account and other digital channels to enhance publicunderstanding of the products and promote product adoption.
Special Session on OsteoporosisManagement
Special Session on HBV Infection andAccurate Diagnosis and Treatment ofLiver Cancer
Special Session on Vitamin D and BoneMetabolism
Academic Symposium on "Laboratory Medicineand Management of Chronic Disease"
Special Session on Coagulation
Gastrointestinal tumor, kidney disease, nasopharyngeal cancer, prenatalscreening, VD, growth and development, diabetes, prostate cancer, anemia, livercancer, bone metabolism disease, thrombosis 1, thrombosis 2, breast cancerNCCL EQA performance, 25-OH VD approved by FDA, Liver ?brosis interlaboratoryEQA program, GADA included in recommended products for prevention andtreatment of liver disease.Respiratory infection and drug monitoringColorectal cancer, AMH, ovarian cancer, hypertension, physical examinationpackage, TG and TGAbThyroid test, lung cancer, gastric function, PTHGastric functionSCCA false positive, gastric function, GADAVDiXLAB advantage, T8 emergency series, T8 design, T8 material selectionRecent policies and centralized procurement results
Disease diagnosis andtreatmentProduct recommendationNew productrecommendationGuidelines andconsensusPrecise testingAcademic literatureCase sharingClinical medicationSATLARS T8Policy interpretation
TypeNumber of articlesTheme
Industry exchange and cooperation | Community Commonweal
73/Environmental, Social and Governance (ESG) Report 2024/74Environmental, Social and Governance (ESG) Report 2024
Industry exchange and cooperation | Community Commonweal
Multi-center Research on Aldosterone and Renin Reference Interval Establishmentin Different Regions of ChinaOn Feb. 23, 2024, Snibe, in collaboration with PekingUniversity People's Hospital and multiple clinicalinstitutions across China, launched "Multi-centerResearch on Aldosterone and Renin Reference IntervalEstablishment in Different Regions of China". The aim wasto establish a reference interval for aldosterone and reninbased on chemiluminescence small molecule "sandwichmethod", and standardize the screening and diagnosisof primary aldosteronism in medical institutions in China,especially in primary medical institutions.
Collaborative assignment completed, to be releasedCollaborative assignment completed, to be releasedCollaborative assignment completed, to be releasedCollaborative assignment of trueness samplescompleted, to be releasedCollaborative assignment of trueness samplescompleted, to be releasedCollaborative assignment of trueness samplescompleted, to be releasedCollaborative assignment of trueness samplescompleted, to be releasedCollaborative assignment, uniformity and stability testscompleted, to be releasedInterchangeability test completed and report issuedCollaborative assignment completed, to be releasedCollaborative assignment completed, to be releasedCollaborative assignment completed, to be releasedCollaborative assignment completed, to be releasedReleasedCollaborative assignment completed, to be releasedCollaborative assignment completed, to be released
●Driving industry standardization
Engaging in standards development and standard system establishmentSnibe actively integrates into the domestic and foreign standardization system. The Company not only participates in the researchof national and international standards, but also contributes to the formulation of national standards, industry standards and groupstandards in an all-round way. With excellent professional capabilities and extensive industry experience, Snibe demonstrates itsleadership in facilitating the mutual recognition of test results.The Company has participated in the evaluation of the interchangeability of reference materials in the proinsulin project of theNational Institute of Metrology of China, the inter-lab comparison study of the CSP standardization plan of the United States CDCfor parathyroid hormone and free testosterone projects, the value assignment of the third-generation TSH harmonization panelorganized by the IFCC C-STFT.During the reporting period, the Company engaged in the development and collaborative calibration of 16 national standards,national references, and international standards, and led or participated in the drafting of 15 reagent-related national standards,industry standards, and group standards, further strengthening the traceability consistency and mutual recognition of the resultsof the above immunoassay kits. By doing so, scienti?c norms and guidance are in place for the industry development, e?ectivelypromoting the standardization process of the industry.During the reporting period, the development of standards and references, as well as the compilation of national/industry/groupstandards that Snibe is involved in include:
AFPTSHCMVFIBPROGTESTTBILLH/HSV-1/2 IgGHBs AgAnti-HCVHP AgSAAanti-TgAbβ2-MG
Alpha-fetoproteinThyroid stimulating hormoneCytomegalovirus (nucleic acid)FibrinogenProgesteroneTestosteroneTotal bilirubinLuteinizing hormoneTestosterone, dehydroepiandrosterone,dehydroepiandrosterone sulfate,4-androstenedione frozen human serumHerpes simplex virus type 1+2 IgG antibodyHepatitis B virus surface antigenHepatitis C virus antibodyHelicobacter pylori antigen (colloidal gold)Serum amyloid AAntithyroglobulin antibodyβ2-microglobulin
Nationalstandards
Nationalreferences
Internationalstandards
Type
AssayAbbreviation
NameStatus
We participated in standard drafting,and the standard was released inOctoberWe participated in standard drafting,and the standard was released inOctoberWe participated in standard drafting,and the standard project proposalwas completedWe participated in standard drafting,and the standard is undergoing thesolicitation of comments stageWe led standard drafting, and thestandard was submitted forapprovalWe participated in standard drafting,and the standard was implementedin SeptemberWe participated in standard drafting,and the standard was implementedin NovemberWe participated in standard drafting,and the standard was submitted forapprovalWe participated in standard drafting,and the standard was submitted forapprovalWe participated in standard drafting,and the standard was released inJanuaryWe participated in standard drafting,and the standard was released inMarchWe participated in standard drafting,and the standard project proposalwas completedWe participated in standard drafting,and the standard project proposalwas completedWe participated in standard drafting,and the standard project proposalwas completedWe participated in standard drafting,and the standard was released inOctober
Assay method of glucose oxidaseactivityAssay method of PfAgoendonuclease activityEvaluation method for enterpriseintelligent manufacturingperformance and capabilityMedical equipment operation andmaintenance service Part 1: Generalrequirements17 α-hydroxyprogesterone assaykit (labeled immunoassay)Interleukin-6 (IL-6) assay kit(labeled immunoassay)Treponema pallidum antibody testkit (luminescence immunoassay)Transferrin assay kit(immunoturbidimetry)N-acetyl-β-D-glucosaminidaseassay kitQuantitative con?rmation methodsin clinical examinationQuality control requirements forimmediate examination of cardiacmarkersVascular endothelial growth factorassay kit (magnetic particle basedchemiluminescent immunoassay)Immunoassay - evaluation ofmeasurement uncertaintyGuidelines for the construction ofintelligent medical laboratoryQuality control speci?cations forautomated nucleic acid testingsystems
Research Use Enzyme (SAC/SWG11)Research Use Enzyme (SAC/SWG11)Industrial Process Measurement andControl (SAC/TC124)Medical Equipment Industrializationand Application Service (SAC/SWG26)Clinical Laboratory Testing and InVitro Diagnostic Test Systems (SAC/TC136)Clinical Laboratory Testing and InVitro Diagnostic Test Systems (SAC/TC136)Clinical Laboratory Testing and InVitro Diagnostic Test Systems (SAC/TC136)Clinical Laboratory Testing and InVitro Diagnostic Test Systems (SAC/TC136)Clinical Laboratory Testing and InVitro Diagnostic Test Systems (SAC/TC136)China Association for QualityInspectionChina Association forStandardizationChina International Associationfor Promotion of Science andTechnologyChinese Society for MeasurementChina Inspection and Testing SocietyChina Inspection and Testing Society
Nationalstandardformulation
Industrystandardformulation
Groupstandardformulation
TypeNameSponsorStatus
Industry exchange and cooperation | Community Commonweal
75/Environmental, Social and Governance (ESG) Report 2024/76Environmental, Social and Governance (ESG) Report 2024
Industry exchange and cooperation | Community Commonweal
Driving laboratory quality management standardizationLaboratory quality management and testing competency serve as fundamental safeguards for achieving inter-institutionalconsistency in diagnostic outcomes, forming the essential basis for mutual recognition of test results. Guided by national policies,Snibe has developed the iXLAB intelligent management system fully compliant with the accreditation requirements and qualitymanagement requirements of ISO 15189, the most authoritative medical laboratory competence accreditation standard in the world.To popularize the ISO 15189 certi?cation, in 2024, Snibe held ISO 15189 internal auditor training courses in Changsha and Shenzhen,covering more than 660 students. We also actively promoted online education. For example, we set up ISO 15189 column throughour WeChat o?cial account "Snibe IVD". 13 articles were released and 13 live training sessions were conducted throughout the year.The Company continues to improve service solutions, driving the standardization in the ?eld of health care and intelligent laboratoryconstruction, and the implementation of the "test results mutual recognition strategy".
●International exchanges and cooperation
Strategic cooperation
In 2024, we reached meaningful cooperation with several authoritative medical laboratory associations around the world, includingthe European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), the German Society of Clinical Chemistry andLaboratory Medicine (DGKL), the Arab Federation of Clinical Biology (AFCB), and many other global institutions. The o?cial executionof a Memorandum of Understanding (MoU) marks the Company's strategic expansion and collaborative advancement within theglobal medical laboratory sector.
On Aug. 26, 2024, the EuropeanFederation of Clinical Chemistryand Laboratory Medicine (EFLM)and Snibe signed a Memorandumof Understanding in Shenzhen.On Dec. 2, 2024, in the presence ofHis Excellency Fahad bin Al-jalajel,Minister of Health of the Kingdomof Saudi Arabia, Snibe signed aMemorandum of Understandingwith the Saudi National UnifiedProcurement Company (NUPCO).
Supporting clinical testing in countries of the Belt and Road InitiativeSnibe actively responds to the "Belt and Road" initiative, vigorously advances business expansion in Africa, and is committed tostrengthening China-Africa cooperation in the process of "going global" to achieve mutual bene?t and win-win results.the Europea
On Mar. 7, 2024, Snibe and theInternational Union of ClinicalChemistry and Laboratory Medicine(IFCC) jointly held the Snibe Dayseries academic lectures onlaboratory medicine in Algeria.
Besides, we also played host tointernational delegations to promoteinternational exchanges and theintroduction of technology in thecountries of the Belt and RoadInitiative, and to deepen the learningand promotion of Chinese medicaldevice products in relevant countries.
In August 2024, with the supportof the International Exchange andCooperation Center of the NationalHealth Commission, Snibe organizedthe "Belt and Road"Symposium onLaboratory Medicine Developmentand Cooperation.
●Support for research and education
Supporting scienti?c work
Snibe actively ful?lls its corporate social responsibilities by contributing its fair share to diagnostic knowledge promotion, diagnostictalent cultivation, education, and medical research.
COMMUNITY COMMONWEAL
Industry exchange and cooperation | Community Commonweal
77/Environmental, Social and Governance (ESG) Report 2024/78Environmental, Social and Governance (ESG) Report 2024
Industry exchange and cooperation | Community Commonweal
Medical laboratory accreditation and quality management training course
The "Medical Laboratory Accreditation and Quality Management Training Course", jointly sponsored by theLaboratory Medicine Committee of the Guangdong Association of Integrative Medicine and the LaboratoryMedicine Committee of the Guangdong Provincial Association of Chinese Medicine, organized by theGuangdong Provincial Hospital of Traditional Chinese Medicine and co-organized by Snibe, was held at Snibe'sheadquarters on November 21 and 22.
Supporting the construction of biomedical discipline
In Jun. 2024, Snibe donated RMB 5 million to SMART Foundation to support the construction and developmentof Shenzhen Medical Academy of Research and Translation, the construction of biomedical discipline, thecultivation of biomedicine talents, and the research of cutting-edge technologies in biomedicine.
Snibe has been closely watching the clinical chemistry and laboratory medicine industry for emerging outstanding young scientists,and has been sponsoring the IFCC Distinguished Award for Laboratory Medicine and Patient Care to recognize and encourageindividuals who have made unique contributions to laboratory medicine and its application in improving patient care, as well asindividuals who have made a global impact in clinical medicine.
SNIBE INDIA is also actively ful?lling its social responsibilities to support the development of local medical education and research.
Empowering global diagnostics talents
Snibe actively promotes the local talent training program. For example, we o?er multi-batch, systematic technical training coursesfor African healthcare practitioners covering the operation of new diagnostic techniques, disease control strategies, and more.China-Africa cooperation is a pivotal driver for the global health development. Snibe is committed to deepening and advancingChina-Africa medical cooperation with practical actions, actively interacting with the China-Africa Hospital Alliance, and working withmembers of the Alliance to jointly promote China-Africa health undertakings to a new level.
●Supporting community commonweal
Education is the cornerstone of national development. We actively contribute to the advancement of China's educational sectorthrough tangible initiatives.In the past practice, we not only emphasized the management of the "Snibe Education Award" established at Tongxin ForeignLanguage School in Pingshan District, Shenzhen, but also warmly received the students from Shenzhen Senior High School to visitthe Company, providing them with an opportunity to deeply understand medical devices, helping them broaden their horizons andstimulating their interest in scienti?c exploration.At the same time, Snibe actively engaged in agricultural assistance activities. We have purchased Heilongjiang high-quality rice,Jiangxi cooking wine, etc. through the government platform, and continued to contribute to rural revitalization and sustainabledevelopment with practical actions.
Co-organizing the Lesotho training courseon laboratory medical devices (Beijing)
Organizing the training course on pediatriccritical care for developing countries(Shenzhen)
Industry exchange and cooperation | Community Commonweal
79/Environmental, Social and Governance (ESG) Report 2024/80Environmental, Social and Governance (ESG) Report 2024
Industry exchange and cooperation | Community Commonweal
Sponsoring outstanding scholars
Professor Etienne Cavalier (Head of the Department of Clinical Chemistry, University of Liege, Belgium) is thewinner of the 2024 IFCC Distinguished Award for Laboratory Medicine and Patient Care sponsored by Snibe. Theaward recognizes individuals who have made unique contributions to laboratory medicine and its applicationin improving patient care, as well as individuals who have made a global impact in clinical medicine.
Driving the development of medical scienceresearchSNIBE DIAGNOSTIC (INDIA) PRIVATE LIMITED, Snibe's wholly-owned subsidiary, has set up a social responsibility committeethat formulated and adopted relevant CSR mechanisms. SNIBEINDIA has donated Rs. 800,000 and Rs. 1.66 million to theAll India Institute of Medical Science (AIIMS) and the IndianInstitute of Technology Jodhpur for two consecutive years. Thefulfillment of corporate social responsibility has underpinnedthe development of medical scientific research.
Key Performance Indicator Table
Direct?emissions?(Scope?1)Indirect?emissions?(Scope?2)Total?emissions?(Scope?1?and?2)Carbon?emission?intensity?per?unit?of?revenue
Tons?of?CO
?equivalentTons?of?CO
?equivalentTons?of?CO
?equivalentTons?of?CO
?equivalent/10,000?RMB?revenue
452.82
12,288.5412,741.36?
0.0324
?1,138.78??14,213.66??15,352.44?
0.0339
IndicatorUnit20232024
Greenhouse Gas Emissions
①
Purchased?electric?powerNatural?gas?consumptionDiesel?consumptionGasoline?consumptionDirect?energy?consumptionIndirect?energy?consumptionTotal?energy?consumptionEnergy?consumption?intensity
kWhm
TonsTonsTons?of?standard?coalTons?of?standard?coalTons?of?standard?coalTons?of?standard?coal/?10,000?RMB
21,735,492.00?51,093.00?
12.60
27.30
120.57
?2,671.29??2,791.86?
0.0071
26,480,307.55
?55,181.00??12.09??27.33??124.84?
?3,254.43?
?3,379.27?
0.0075
IndicatorUnit20232024Energy source
Environmental indicators
Economic Indicators
Operating?revenue
Cost?of?operations
Total?Value?of?Assets
Asset-liability?ratio
Net?profit?attributable?to?shareholders?of?listed?companies
EPS
10,000?RMB10,000?RMB10,000?RMB%10,000?RMBRMB/share
392,965.57106,247.60822,248.88
8.25
165,365.32
2.1054
?453,540.45??126,653.49??961,945.35??10.84??182,845.66??2.3271?
IndicatorUnit20232024
Water?intakeWater?intake?intensityVolume?of?reject?water?recovered
m
m
/?10,000?RMBm
235,533.00
0.5994
19,396.80
244,266.00
0.5386
20,870.10
IndicatorUnit20232024Water resource
Biohazard?waste
Hazardous?waste
General?industrial?solid?waste
Total?monetary?value?of?significant?fines
Total?number?of?non-monetary?sanctions
Cases?brought?through?dispute?settlement?mechanisms
Number?of?staff?involved
Male?employees
Female?employees
Male?employees?in?management
Female?employees?in?management
Employees?under?30?years?old
TonsTonsTons
RMBCasesCases
Persons%%%%%
149.3
?2.08??87.00?
95.5
0.882
51.6
2,627?
64.94?
35.06
70.71
29.29
62.31
??2,841??63.57??36.43??69.05??30.95??62.44?
Indicator
Indicator
Indicator
Unit
Unit
Unit
20242023
20232024
20232024
Waste
Environmental compliance
Diversity and equal employmentSocial indicators
Key Performance Indicator Table
①During?the?reporting?period,?Snibe?commissioned?SGS,?an?international?authoritative?certification?body,?to?verify?our?greenhouse?gas?emissions?in?2024,?and?obtained?the?ISO?14064-12018?Greenhouse?Gas?Verification?Statement?Certificate?issued?by?SGS.?To?enhance?data?comparability?and?reliability,?the?Company?re-calculated?and?retroactively?adjusted?the?greenhouse?gas?emissions?in?2023.
Economic indicators | Environmental indicators | Social indicators
81/Environmental, Social and Governance (ESG) Report 2024/82Environmental, Social and Governance (ESG) Report 2024
Economic indicators | Environmental indicators | Social indicators
Employee compensation and benefits
Attraction and Retention of Employees
Employees?aged?30-40?years?oldEmployees?aged?40-50?years?oldEmployees?over?50?years?oldCollege?degree?or?belowUndergraduatesPostgraduatesPhD?students
Employee?labor?contract?signing?rateEmployee?social?insurance?coverage?rate
Number?of?new?employeesTurnover?Rate?
%%%%%%%
%%
Persons%
33.80
3.43
0.46
29.62
52.87
17.24
0.27
??33.09??4.05??0.42??27.49??52.76??19.43?
?0.32?
12.49
?563??9.56?
Indicator
Indicator
Indicator
Unit
Unit
Unit
20232024
2023
2023
2024
2024
Employee training and developmentTotal?training?durationTotal?number?of?trainees
HoursTimes
164,366
33,109
?86,482??13,298?
IndicatorUnit20232024
Diversity and equal employment
Occupational health and safety
Investment?amount?in?environmental?and?occupational?health?&?safetyCoverage?rate?of?occupational?health?examination
10,000?RMB%
/
409.5
?100?
IndicatorUnit20232024
Key Performance Indicator Table
Total?number?of?discrimination?incidents?during?the?reporting?periodCases00
IndicatorUnit20232024
Anti discrimination
Quality?management?system?certificationExternal?regulatory?reviewThird?party?quality?system?auditOverall?satisfaction?with?customer?complaint?handlingEvents?where?fines?or?penalties?are?imposed?for?violations?of?regulationsEvents?subject?to?warnings?due?to?violations?of?regulationsEvents?that?violated?the?voluntary?codeEvents?of?Product?recall?quantity
PcsTimesTimes%CasesCasesCasesPcs
?6??8?
IndicatorUnit20232024
Quality of product and service
Total?number?of?R&D?personnelR&D?investment?amountCumulative?number?of?patent?applicationsValid?patents?grantedValid?invention?patents?grantedChemiluminescence?immunoassay?reagent?projects?provided?globally
Persons10,000?RMBPcsPcsPcsItems
36,604.71
45,358.80
IndicatorUnit20232024
Product R&D
Occupational health and safetyDeaths?and?mortality?rate?of?employee?caused?by?work?injuryOccupational?injuries?excluding?deaths?and?serious?injuriesLosses?of?working?hours?due?to?occupational?injuries
Persons;%PersonsHours
635.04
?6??1,773.04?
IndicatorUnit20232024
Key Performance Indicator TableEconomic indicators | Environmental indicators | Social indicators
83/Environmental, Social and Governance (ESG) Report 2024/84Environmental, Social and Governance (ESG) Report 2024
Economic indicators | Environmental indicators | Social indicators
Total?number?of?new?suppliersNumber?of?suppliers?disqualified?due?to?quality?issuesPercentage?of?the?Chinese?Mainland?suppliers
SuppliersSuppliers%
95.21
95.90
IndicatorUnit20232024Supplier management
Events?where?fines?or?penalties?are?imposed?for?violations?of?regulations
Events?subject?to?warnings?due?to?violations?of?regulations
Events?that?violated?the?voluntary?code
Number?of?anti-commercial?bribery?trainings
Proportion?of?employees?receiving?anti-commercial?bribery?trainings
Proportion?of?employees?signing?anti-commercial?bribery?commitments
CasesCasesCases
Times%%
Indicator
Indicator
Unit
Unit
20232024
20232024
Marketing management
Anti-corruption
The?total?number?of?confirmed?leaks,?theft,?or?loss?of?customer?information
The?total?number?of?confirmed?complaints?received?regarding?violations?of?customer?privacy
CasesCases
IndicatorUnit20232024Customer privacy
Key Performance Indicator Table
Issue Index of "Shenzhen Stock Exchange Self-Regulation Guidelines for Listed
Companies No. 17 - Sustainable Development Report (Trial)"
Environment
Society
Governancerelated tosustainabledevelopment
Addressing?Climate?ChangePollutant?emissionsWaste?disposalEcosystem?and?biodiversity?conservationEnvironmental?compliance?managementEnergy?utilizationWater?utilizationCircular?economyRural?revitalizationSocial?contributionInnovation-driven?developmentEthics?of?science?and?technologySupply?chain?securityEqual?treatment?of?SMEsSafety?and?quality?of?products?and?servicesData?security?and?customer?privacy?protectionEmployeesDue?diligenceCommunications?with?stakeholdersAnti-commercial?bribery?and?anti-corruptionAnti-unfair?competition
Addressing?Climate?ChangeGreen?OperationGreen?Operation/Environmental?and?occupational?health?and?safety?managementAddressing?Climate?ChangeGreen?OperationGreen?OperationCommunity?CommonwealIndustry?exchange?and?cooperation,Community?CommonwealFocusing?on?R&D?and?InnovationFocusing?on?R&D?and?InnovationSupply?Chain?ManagementSupply?Chain?Management,Responsible?MarketingProduct?Quality?and?Safety,Customer?Service?QualityCompliance?in?OperationAttraction?and?Retention?of?Talents,?Employee?Training?and?Development,Occupational?Health?and?SafetyCompliance?in?OperationESG?governanceCompliance?in?OperationResponsible?Marketing
DimensionNoIssueSection
Appendix
85/Environmental, Social and Governance (ESG) Report 2024/86Environmental, Social and Governance (ESG) Report 2024
Economic indicators | Environmental indicators | Social indicators
GRI2：General DisclosuresThe?organization?and?its?reporting?practices2-12-22-32-4Activities?and?workers2-62-7Governance2-92-102-112-122-142-162-172-182-20Strategy,?policies?and?practices2-222-232-242-252-26
Organizational?detailsEntities?included?in?the?organization’s?sustainability?reportingReporting?period,?frequency?and?contact?pointRestatements?of?informationActivities,?value?chain?and?other?business?relationshipsEmployeesGovernance?structure?and?compositionNomination?and?selection?of?the?highest?governance?bodyChair?of?the?highest?governance?bodyRole?of?the?highest?governance?body?in?overseeing?the?management?of?impactsRole?of?the?highest?governance?body?in?sustainability?reportingCommunication?of?critical?concernsCollective?knowledge?of?the?highest?governance?bodyEvaluation?of?the?performance?of?the?highest?governance?bodyProcess?to?determine?remuneration?Statement?on?sustainable?development?strategyPolicy?commitmentsEmbedding?policy?commitmentsProcesses?to?remediate?negative?impactsMechanisms?for?seeking?advice?and?raising?concerns
ABOUT?THIS?REPORTABOUT?THIS?REPORTABOUT?THIS?REPORTABOUT?THIS?REPORT,?Key?Performance?Indicator?TableSupply?Chain?Management,Responsible?Marketing,Customer?Service?QualityAttraction?and?Retention?of?TalentsCorporate?governanceCorporate?governanceCorporate?governanceCorporate?governanceESG?governanceESG?governance Corporate?governanceCorporate?governanceCorporate?governanceMESSAGE?FROM?THE?CHAIRMANCompliance?in?OperationCompliance?in?Operation,?Supply?Chain?Management,Responsible?MarketingCompliance?in?OperationCompliance?in?Operation
Indicator No.Indicator NameReport Chapter
GRI Index Table
REGULATING?CORPORATE?GOVERNANCE,STRICTLY?CONTROLLING?THE?QUALITY?OF?PRODUCTS?AND?SERVICES,TALENT?EMPOWERMENT,PROMOTING?GREEN?OPERATION,AppendixESG?governanceESG?governanceESG?governanceESG?governanceKey?Performance?Indicator?TableAddressing?Climate?ChangeCommunity?CommonwealSupply?Chain?ManagementCompliance?in?OperationKey?Performance?Indicator?TableAddressing?Climate?Change,Key?Performance?Indicator?TableAddressing?Climate?ChangeAddressing?Climate?ChangeAddressing?Climate?Change,Key?Performance?Indicator?Table
2-27Stakeholder?engagement2-29GRI3：Material Topics3-13-23-3GRI201：Economic Performance201-1201-2GRI203：Indirect Economic Impacts203-1GRI204：Procurement Practices204-1GRI205：Anti-corruption205-2GRI206：Anti-competitive Behavior206-1GRI302：Energy302-1302-3302-4302-5
Compliance?with?laws?and?regulations
Approach?to?stakeholder?engagement?Process?to?determine?material?topicsList?of?material?topicsManagement?of?material?topicsDirect?economic?value?generated?and?distributedFinancial?implications?and?other?risks?and?opportunities?due?to?climate?changeInfrastructure?investments?and?services?supportedProportion?of?spending?on?local?suppliersCommunication?and?training?about?anti-corruption?policies?and?proceduresLegal?actions?for?anti-competitive?behavior,?anti-trust,?and?monopoly?practicesEnergy?consumption?within?the?organizationEnergy?intensityReduction?of?energy?consumptionReductions?in?energy?requirements?of?products?and?services
Indicator No.Indicator NameReport Chapter
AppendixAppendix
87/Environmental, Social and Governance (ESG) Report 2024/88Environmental, Social and Governance (ESG) Report 2024
GRI303：Water and Effluents303-1303-2303-3303-4GRI305：Emissions305-1305-2305-4GRI306：Effluents and Waste306-1306-2306-3306-5GRI308：Supplier Environmental Assessment308-1308-2SocietyGRI401：Employment401-1401-2GRI403：Occupational Health and Safety403-1403-2
Appendix
Interactions?with?water?as?a?shared?resourceManagement?of?water?discharge-related?impactsWater?withdrawalWater?dischargeDirect?(Scope?1)?GHG?emissionsEnergy?indirect?(Scope?2)?GHG?emissionsGHG?emissions?intensityWaste?generation?and?significant?waste-related?impactsManagement?of?significant?waste-related?impactsWaste?generatedWaste?directed?to?disposalNew?suppliers?that?were?screened?using?environmental?criteriaNegative?environmental?impacts?in?the?supply?chain?and?actions
New?employee?hires?and?employee?turnoverBenefits?provided?to?full-time?employees?that?are?not?provided?to?temporary?or?part-time?employeesOccupational?health?and?safety?management?systemHazard?identification,?risk?assessment,?and?incident?investigation
Green?OperationGreen?OperationGreen?Operation,?Key?Performance?Indicator?TableGreen?OperationAddressing?Climate?Change,?Key?Performance?Indicator?TableAddressing?Climate?Change,?Key?Performance?Indicator?TableAddressing?Climate?Change,?Key?Performance?Indicator?TableGreen?OperationGreen?OperationGreen?OperationGreen?OperationSupply?Chain?ManagementSupply?Chain?Management
Attraction?and?Retention?of?Talents,Key?Performance?Indicator?TableAttraction?and?Retention?of?Talents,?Employee?Training?and?Development
Environmental?and?occupational?health?and?safety?managementEnvironmental?and?occupational?health?and?safety?management,?Occupational?Health?and?Safety
Indicator No.Indicator NameReport Chapter
Appendix
403-3403-4403-5403-6403-7403-8403-9GRI404：Training and Education404-1404-2404-3GRI405：Diversity and Equal Opportunity405-1GRI406：Non-discrimination406-1GRI416：Customer Health and Safety416-1GRI417：Marketing and Labeling417-1
Occupational?health?servicesWorker?participation,?consultation,?and?communication?on?occupational?health?and?safetyWorker?training?on?occupational?health?and?safetyPromotion?of?worker?healthPrevention?and?mitigation?of?occupational?health?and?safety?impacts?directly?linked?by?business?relationshipsWorkers?covered?by?an?occupational?health?and?safety?management?systemWork-related?injuries
Average?hours?of?training?per?year?per?employeePrograms?for?upgrading?employee?skills?and?transition?assistance?programsPercentage?of?employees?receiving?regular?performance?and?career?development?reviewsDiversity?of?governance?bodies?and?employees
Incidents?of?discrimination?and?corrective?actions?taken
Assessment?of?the?health?and?safety?impacts?of?product?and?service?categoriesRequirements?for?product?and?service?information?and?labeling
Environmental?and?occupational?health?and?safety?management,?Occupational?Health?and?SafetyEmployee?care?and?communicationEnvironmental?and?occupational?health?and?safety?management,?Occupational?Health?and?SafetyEnvironmental?and?occupational?health?and?safety?management,Occupational?Health?and?SafetyEnvironmental?and?occupational?health?and?safety?managementEnvironmental?and?occupational?health?and?safety?managementOccupational?Health?and?Safety,Key?Performance?Indicator?TableEmployee?Training?and?Development,Key?Performance?Indicator?TableEmployee?Training?and?DevelopmentEmployee?Training?and?Development,?Key?Performance?Indicator?TableCorporate?governance,?Attraction?and?Retention?of?Talents,?Key?Performance?Indicator?TableAttraction?and?Retention?of?Talents,?Key?Performance?Indicator?TableProduct?Quality?and?Safety,?Customer?Service?QualityResponsible?Marketing
Indicator No.Indicator NameReport Chapter
89/Environmental, Social and Governance (ESG) Report 2024/90Environmental, Social and Governance (ESG) Report 2024
Shenzhen New Industries Biomedical Engineering Co., Ltd.Add?Snibe?Building,No.23,?Jinxiu?East?Road,?Pingshan?District,?Shenzhen,?P.R.?ChinaWeb?www.snibe.comE-mail?snibeinfo@snibe.cnZip?code?518122